FeatureID,Name,Formula,MW,KEGG Pathways,Metabolika Pathways,name4plot,C,H,N,O,S,P,F,Cl,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature0342,NA,C8 H16 N2 O9,284.08565,NA,NA,Feature0342,8,16,2,9,0,0,0,0,2,1.125,1,31.799999999999997,2,-7,3,-3,-9,Carbohydrate,2376674.2324166126,3624057.292081847,1.5248439363929527,0.6086615943388597,0.47277164638903557,0.6078492596430458,Upregulated
Feature0341,3-Deoxytetronic acid,C4 H8 O4,120.04228,NA,NA,3-Deoxytetronic acid,4,8,0,4,0,0,0,0,2,1,0,60.3,1,-3,-Inf,-0.5,-3,Carbohydrate,1801418.6861192132,3075628.674909123,1.7073369442697044,0.7717478034487937,0.18066348360202208,0.3462599380783044,Upregulated
Feature0340,6-Deoxy-D-arabino-hexos-2-ulose,C6 H10 O5,162.05281,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Fructose and mannose metabolism;Other,Superpathway of butirocin biosynthesis;Other,6-Deoxy-D-arabino-hexos-2-ulose,6,10,0,5,0,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,2273796.061721057,720571.305698264,0.31690234574197346,-1.657889756158736,0.2931595996110962,0.4397393994166443,Downregulated
Feature0339,Oleic acid,C18 H34 O2,282.2559,Biosynthesis of plant secondary metabolites;Other,Other,Oleic acid,18,34,0,2,0,0,0,0,1.8888888888888888,0.1111111111111111,-1.666666666666667,107.8,2,0,0,0.0588235294117647,0,Lipid,1105967.7087129063,1466367.4751009666,1.3258682541531734,0.40693742814828604,0.6063925723653556,0.7172759172773918,Upregulated
Feature0338,DL-TYROSINE,C9 H11 N O3,181.07387,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Central carbon metabolism in cancer;Other,Superpathway of chorismate metabolism;Superpathway of betalain biosynthesis;Other,DL-TYROSINE,9,11,1,3,0,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,4351198.0235445,3000162.93595714,0.6895027345855425,-0.5363718213711993,0.03181987861153267,0.2315403933009398,Downregulated
Feature0337,Mevalonic acid,C6 H12 O4,148.07361,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Biosynthesis of terpenoids and steroids;Other,Superpathway of branched chain amino acid biosynthesis;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of L-threonine metabolism;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of L-isoleucine biosynthesis I;Other,Mevalonic acid-peak2,6,12,0,4,0,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,1844531.7005040515,519739.7964671547,0.2817733066474956,-1.8273931482197092,0.5048784561037882,0.6256102608242593,Downregulated
Feature0336,MFCD01318772,C8 H13 N3 O2,183.10073,NA,NA,MFCD01318772,8,13,3,2,0,0,0,0,1.625,0.25,0,60.3,4,2,-0.3333333333333333,0,-1,Lipid,5362443.899385546,2157908.2755248533,0.4024113475149113,-1.3132571069092664,7.668989727023349e-4,0.13113972433209928,Downregulated
Feature0335,Leu-arg,C12 H25 N5 O3,287.19584,NA,NA,Leu-arg,12,25,5,3,0,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,654940.1643358817,754910.6653604064,1.1526406631755377,0.20494282152896615,0.306950774314749,0.4544466009335245,Upregulated
Feature0334,Ser-Leu,C9 H18 N2 O4,218.12657,Other,NA,Ser-Leu,9,18,2,4,0,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,1010626.0780687347,4489106.099804697,4.441906059245172,2.15117888201271,0.002640113081263813,0.1590879919784982,Upregulated
Feature0333,beta-D-Ethyl glucuronide,C8 H14 O7,222.07387,NA,NA,beta-D-Ethyl glucuronide-peak5,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,70979.56610889004,157665.1740255751,2.2212755398321304,1.1513883642009803,0.09861382477147769,0.28085732573866523,Upregulated
Feature0332,NA,C8 H11 N O5,201.06375,NA,NA,Feature0332,8,11,1,5,0,0,0,0,1.375,0.625,0.25,53.175,4,-1,-1,0.1111111111111111,-2,Lignin,3319624.009788627,1509969.529396083,0.45486161232224265,-1.136500410201109,0.31699715983179705,0.4652919685084746,Downregulated
Feature0331,NA,C9 H13 N O4 S,231.05648,NA,NA,Feature0331,9,13,1,4,1,0,0,0,1.4444444444444444,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Lignin,790819.409824469,1494016.610961976,1.8892007358463663,0.9177760025329901,0.41448707503973037,0.5515742399361392,Upregulated
Feature0330,"8-Azabicyclo[3.2.1]octane-1,2,3,4-tetrol",C7 H13 N O4,175.08438,NA,NA,"8-Azabicyclo[3.2.1]octane-1,2,3,4-tetrol",7,13,1,4,0,0,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,387654.463108267,163102.731416053,0.420742560548053,-1.2489903324356866,0.14758703567854903,0.3115726308769368,Downregulated
Feature0329,NA,C21 H36 N2 O6 S4,540.14577,NA,NA,Feature0329,21,36,2,6,4,0,0,0,1.7142857142857142,0.2857142857142857,-0.4761904761904763,73.87142857142857,5,-1,-0.7777777777777778,-0.3333333333333333,-7,Lipid,119326.64182731233,158377.8430325483,1.3272630538094776,0.4084543306299145,0.5316436222065851,0.6493647099809005,Upregulated
Feature0328,3-methoxyanthranilic acid,C8 H9 N O3,167.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,3-methoxyanthranilic acid,8,9,1,3,0,0,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,1300068.1402222952,1357631.1957216333,1.044276952659955,0.06250437976314258,0.8576224363622695,0.8997143350794361,Upregulated
Feature0327,cis-trihomoaconitic acid,C9 H12 O6,216.0633,Metabolic pathways;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Other,NA,cis-trihomoaconitic acid-peak2,9,12,0,6,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,4,-2,-0.6666666666666666,0.16666666666666666,-2,Tannin,417511.89928004233,362984.6130786054,0.8693994439548578,-0.20190892198107827,0.6553432748633721,0.7623380952492287,Downregulated
Feature0326,asp-leu,C10 H18 N2 O5,246.12159,Metabolic pathways;Other,NA,asp-leu-peak2,10,18,2,5,0,0,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,466002.8799981958,1230980.89090909,2.6415735690600366,1.4013975901818057,0.5307342886057226,0.6493647099809005,Upregulated
Feature0325,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one",C8 H10 O5,186.05284,NA,NA,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one-peak3",8,10,0,5,0,0,0,0,1.25,0.625,0,60.3,4,-1,-0.3333333333333333,0.2727272727272727,-1,Lignin,2484753.1143332995,3835240.3196496866,1.5435096137021023,0.6262144687626613,0.38148725147878815,0.5264704825977581,Upregulated
Feature0324,NA,C13 H11 N7 O4 S,361.05925,NA,NA,Feature0324,13,11,7,4,1,0,0,0,0.8461538461538461,0.3076923076923077,1.5384615384615383,16.453846153846158,12,8,0,0.6666666666666666,0,Lignin,115480.54733430364,103293.91440228959,0.8944702531004198,-0.16089459071874235,0.7351793675175456,0.8216710578137275,Downregulated
Feature0323,4-Undecylbenzenesulfonic acid,C17 H28 O3 S,312.17604,NA,NA,4-Undecylbenzenesulfonic acid-peak2,17,28,0,3,1,0,0,0,1.6470588235294117,0.17647058823529413,-1.1764705882352944,93.8294117647059,4,1,0,0.10344827586206896,0,Lipid,3768488.64467401,4577454.708456347,1.2146659151874175,0.28055956586470093,0.7654067740505784,0.8418556438101702,Upregulated
Feature0322,Genipin,C11 H14 O5,226.0841,NA,NA,Genipin,11,14,0,5,0,0,0,0,1.2727272727272727,0.4545454545454546,-0.3636363636363633,70.66363636363636,5,0,0,0.29411764705882354,0,Lignin,94105.8015672571,279671.4182421933,2.9718828550895777,1.5713772492169622,0.02934519295707435,0.2313912399951807,Upregulated
Feature0321,Ro 20-1724,C15 H22 N2 O3,278.16312,NA,NA,Ro 20-1724,15,22,2,3,0,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,232800.15686752534,1292761.310347262,5.5530946703051685,2.4732919915024065,0.04023189132825429,0.24912498754207058,Upregulated
Feature0320,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.074,NA,NA,Phenyl D-glucopyranosiduronic acid,12,14,0,7,0,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,2356008.7261747867,2077789.8408402067,0.8819109274750879,-0.181295143162609,0.5902215476750486,0.710759751073474,Downregulated
Feature0319,NA,C6 H12 O8 S,244.02539,NA,NA,Feature0319,6,12,0,8,1,0,0,0,2,1.3333333333333333,1,31.799999999999997,1,-7,2.6666666666666665,-4,-8,Carbohydrate,1550487.113267174,2103207.103096281,1.3564815115840725,0.43986938427459293,0.702853859209555,0.7933201975236561,Upregulated
Feature0318,NA,C7 H16 O6,196.09468,NA,NA,Feature0318,7,16,0,6,0,0,0,0,2.2857142857142856,0.8571428571428571,-0.5714285714285712,76.58571428571427,0,-6,-6,-0.75,-6,Carbohydrate,93176.9942320604,183213.007425896,1.9662901656775698,0.9754762360704577,0.07101624751382178,0.2798606815761545,Upregulated
Feature0317,"2,2-Bis(hydroxymethyl)propionic acid",C5 H10 O4,134.05797,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,"2,2-Bis(hydroxymethyl)propionic acid",5,10,0,4,0,0,0,0,2,0.8,-0.4000000000000003,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,6153790.278143817,3721462.31757533,0.6047431175535355,-0.7256056495790364,0.05210671614908735,0.2509929144082799,Downregulated
Feature0316,Adipic acid,C6 H10 O4,146.05797,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of L-isoleucine biosynthesis I;Other,Adipic acid,6,10,0,4,0,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,185970.51543169733,255777.243928657,1.3753644943926504,0.45981400741293715,0.2454025338432239,0.3914989886536033,Upregulated
Feature0315,D-(+)-Mannose,C6 H12 O6,180.06334,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Galactose metabolism;Carbon metabolism;Biosynthesis of phenylpropanoids;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of scopolin and esculin biosynthesis;Homolactic fermentation;Superpathway of CMP-sialic acids biosynthesis;Superpathway of betalain biosynthesis;Other,D-(+)-Mannose,6,12,0,6,0,0,0,0,2,1,0,60.3,1,-5,-Inf,-0.6666666666666666,-5,Carbohydrate,201399.409967367,225251.42276733532,1.1184313936363224,0.16147676189875282,0.780037792805046,0.8501289973969907,Upregulated
Feature0314,N-(2-Hydroxyethyl)glutamine,C7 H14 N2 O4,190.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,N-(2-Hydroxyethyl)glutamine,7,14,2,4,0,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,1988540.0024647533,2786287.1701609166,1.4011723006363324,0.48663437331998977,0.23536185579885902,0.38281812323173786,Upregulated
Feature0313,Glycyl-L-leucine,C8 H16 N2 O3,188.11609,Metabolic pathways;Other,Superpathway of L-lysine degradation,Glycyl-L-leucine,8,16,2,3,0,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,1602575.5730328134,3752221.0265431665,2.3413691620434665,1.2273524211055333,0.10550455627513905,0.28085732573866523,Upregulated
Feature0312,NA,C12 H9 N5 O7 S,367.02222,NA,NA,Feature0312,12,9,5,7,1,0,0,0,0.75,0.5833333333333334,1.8333333333333337,8.04999999999999,11,4,2,0.6,-2,Condensed HC,5385616.623597844,6962321.495851713,1.292762181649788,0.3704568993468771,0.009530674413027513,0.20510808338839256,Upregulated
Feature0311,NA,C28 H43 O4 P,474.28996,NA,NA,Feature0311,28,43,0,4,0,1,0,0,1.5357142857142858,0.14285714285714285,-1.4285714285714288,101.01428571428572,8,4,0.13043478260869565,0.2,3,Lipid,7560752.89015067,9756327.48506386,1.290391000316033,0.367808281730259,0.48916760907205337,0.6174771457433144,Upregulated
Feature0310,NA,C8 H11 O4 P S,234.01153,NA,NA,Feature0310,8,11,0,4,1,1,0,0,1.375,0.5,-0.75,81.675,4,0,-1,0,-2,Lignin,352682.4630387557,520781.1271162217,1.4766289274184692,0.5623073265544134,0.2742802676171653,0.42253987173455193,Upregulated
Feature0309,(E)-Ferulic acid,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,Superpathway of scopolin and esculin biosynthesis;Other,(E)-Ferulic acid,10,10,0,4,0,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,1857463.9405484777,14893818.1344151,8.018361923094565,3.0033075375771805,0.0038711126943812902,0.16328683557815518,Upregulated
Feature0308,3-Hydroxybutyric acid,C4 H8 O3,104.04735,Metabolic pathways;Microbial metabolism in diverse environments;Carbon metabolism;Other,NA,3-Hydroxybutyric acid-peak3,4,8,0,3,0,0,0,0,2,0.75,-0.5,74.55,1,-2,-2,-0.2,-2,Carbohydrate,2632593.144169407,557366.3398983346,0.21171761429705682,-2.239786792467329,0.44882463245205173,0.5836426779414513,Downregulated
Feature0307,"2,4-Dihydroxybenzoic acid",C7 H6 O4,154.02667,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of phenylpropanoids;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Other,"2,4-Dihydroxybenzoic acid",7,6,0,4,0,0,0,0,0.8571428571428571,0.5714285714285714,0.2857142857142856,52.15714285714286,5,1,0.3333333333333333,0.6,1,Lignin,6280809.63329692,6354043.647454093,1.011659963990778,0.01672445732556834,0.8834343482330593,0.9211419118771533,Upregulated
Feature0306,NA,C12 H17 N O4,239.11571,NA,NA,Feature0306,12,17,1,4,0,0,0,0,1.4166666666666667,0.3333333333333333,-0.5,74.55,5,1,0,0.2222222222222222,0,Lignin,6698600.760286267,6605888.859228823,0.98615951235561,-0.020107071943713136,0.9357393043925114,0.9639242231995147,Downregulated
Feature0305,6-Deoxy-3-O-methyl-beta-D-galactopyranose,C7 H14 O5,178.08407,NA,NA,6-Deoxy-3-O-methyl-beta-D-galactopyranose-peak2,7,14,0,5,0,0,0,0,2,0.7142857142857143,-0.5714285714285712,76.58571428571427,1,-4,-2,-0.3333333333333333,-4,Carbohydrate,129500.48184312003,249521.99391831132,1.9268035946042905,0.9462095205015857,0.11253115288209557,0.2809171845669831,Upregulated
Feature0304,NA,C6 H7 N3 O5 P2,262.98597,NA,NA,Feature0304,6,7,3,5,0,2,0,0,1.1666666666666667,0.8333333333333334,0.3333333333333335,50.8,6,1,1,1,-4,Tannin,175984.162795565,382229.08449006797,2.1719516030206134,1.1189919563374577,0.16237274649094258,0.32323524831809103,Upregulated
Feature0303,diphthinate,C13 H22 N4 O4,298.16421,NA,NA,diphthinate,13,22,4,4,0,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,76987.11451832496,145521.15386917966,1.8902014288968032,0.9185399831162274,0.12187850678108822,0.2922180975769106,Upregulated
Feature0302,NA,C3 H9 N4 O2 P,164.04635,NA,NA,Feature0302,3,9,4,2,0,1,0,0,3,0.6666666666666666,0.6666666666666665,41.3,2,0,1.25,1.3333333333333333,-5,Other,838010.8616265063,169889.86961854834,0.2027299136538718,-2.3023691146370964,0.43676989767992175,0.5753220379233701,Downregulated
Feature0301,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one",C8 H10 O5,186.05281,NA,NA,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one-peak2",8,10,0,5,0,0,0,0,1.25,0.625,0,60.3,4,-1,-0.3333333333333333,0.2727272727272727,-1,Lignin,770065.0148386477,2107907.0996188247,2.737310563395087,1.4527591259166819,0.3686414699448993,0.5167023882014572,Upregulated
Feature0300,DL-Nordihydroguaiaretic acid,C18 H22 O4,302.1519,NA,NA,DL-Nordihydroguaiaretic acid,18,22,0,4,0,0,0,0,1.2222222222222223,0.2222222222222222,-0.7777777777777777,82.46666666666667,8,4,0.2857142857142857,0.375,4,Lignin,375528.069147123,8324120.278654594,22.1664396420748,4.470305159038827,0.11715107978369826,0.28618335204303436,Upregulated
Feature0299,N-Acetyl-Î±-D-glucosamine 1-phosphate,C8 H16 N O9 P,301.05637,Metabolic pathways;Galactose metabolism;Phosphotransferase system (PTS);Other,Chitin biosynthesis;Superpathway of CMP-sialic acids biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,N-Acetyl-Î±-D-glucosamine 1-phosphate,8,16,1,9,0,1,0,0,2,1.125,0,60.3,2,-7,3,-3,-9,Carbohydrate,2777051.057463753,4016348.17317788,1.4462637128630835,0.5323306384240547,0.2676895734273317,0.4180357722015865,Upregulated
Feature0298,3-O-methylgallic acid,C8 H8 O5,184.03711,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,3-O-methylgallic acid,8,8,0,5,0,0,0,0,1,0.625,0.25,53.175,5,0,0,0.4545454545454546,0,Lignin,311567.802377776,380324.84604925866,1.2206808378361085,0.28768603909558216,0.47815288106790166,0.6124654881094471,Upregulated
Feature0297,Wikstromol,C20 H22 O7,374.13667,NA,NA,Wikstromol,20,22,0,7,0,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,64833.63844544693,125998.4464046952,1.9434116212791956,0.9585915010697726,0.04812321943772738,0.24912498754207058,Upregulated
Feature0296,Propyl gallate,C10 H12 O5,212.06837,NA,NA,Propyl gallate,10,12,0,5,0,0,0,0,1.2,0.5,-0.20000000000000015,66,5,0,0,0.3333333333333333,0,Lignin,199532.83501104,219965.16976778166,1.1024008642768552,0.14064892422110123,0.78052779293174,0.8501289973969907,Upregulated
Feature0295,D-Sedoheptulose 7-phosphate,C7 H15 O10 P,290.04036,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Biosynthesis of amino acids;Other,Other,D-Sedoheptulose 7-phosphate,7,15,0,10,0,1,0,0,2.142857142857143,1.4285714285714286,0,60.3,1,-9,2.5,-5,-10,Carbohydrate,2187179.8490146734,745328.1885413344,0.3407713311171486,-1.5531241272663447,0.01471229967048057,0.20510808338839256,Downregulated
Feature0294,Acetyl-L-methionine,C7 H13 N O3 S,191.06167,NA,NA,Acetyl-L-methionine,7,13,1,3,1,0,0,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,972974.6016110013,130636.49989595936,0.13426506681639805,-2.896844102753889,0.393569733135345,0.5341303521122539,Downregulated
Feature0293,Dodecyl sulfate,C12 H26 O4 S,266.15528,NA,NA,Dodecyl sulfate-peak2,12,26,0,4,1,0,0,0,2.1666666666666665,0.3333333333333333,-1.333333333333333,98.29999999999998,0,-4,-0.7142857142857143,-0.3333333333333333,-5,Protein,4615100.788007277,4113505.31694813,0.8913142975419768,-0.1659938465857572,0.8027938686950333,0.8641381902116634,Downregulated
Feature0292,Glycolic acid,C2 H4 O3,76.01607,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Other,Other,Glycolic acid-peak2,2,4,0,3,0,0,0,0,2,1.5,1,31.799999999999997,1,-2,2,-1,-2,Carbohydrate,2255536.037007308,3500426.8707947503,1.5519268206590877,0.6340605304880973,0.3893440223453174,0.5326226225683942,Upregulated
Feature0291,NA,C12 H22 N6 O7 P2 S2,488.04681,NA,NA,Feature0291,12,22,6,7,2,2,0,0,1.8333333333333333,0.5833333333333334,0.3333333333333335,50.8,6,-1,2.2,5,-11,Amino Sugar,3542369.60473187,2455963.7520111296,0.6933109827756179,-0.528425480371885,0.6053234913302934,0.7172759172773918,Downregulated
Feature0290,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid,C9 H8 O6 S,244.00407,NA,NA,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid-peak3,9,8,0,6,1,0,0,0,0.8888888888888888,0.6666666666666666,0.6666666666666665,41.3,6,0,-0.5,0.4,-1,Tannin,158118.82784685466,300992.3470661513,1.9035832175386236,0.9287176405101125,0.28021239724419345,0.4278242850781882,Upregulated
Feature0289,NA,C23 H51 N6 O15 P S3,778.23108,NA,NA,Feature0289,23,51,6,15,3,1,0,0,2.217391304347826,0.6521739130434783,-0.08695652173913082,62.77826086956522,2,-13,11.5,-2.8181818181818183,-23,Other,119895.82787336447,224146.077343299,1.8695068987725327,0.9026577949760002,0.050841459858824135,0.24912498754207058,Upregulated
Feature0288,"N'-(2-Thienylcarbonyl)-2,5-bis(2,2,2-trifluoroethoxy)benzohydrazide",C16 H12 F6 N2 O4 S,442.04207,NA,NA,"N'-(2-Thienylcarbonyl)-2,5-bis(2,2,2-trifluoroethoxy)benzohydrazide",16,12,2,4,1,0,6,0,0.75,0.25,0.25,53.175,12,8,0.5555555555555556,0.6363636363636364,5,Condensed HC,106455.5792854249,271869.96259923134,2.553834795922751,1.3526652020916428,0.3314525159788488,0.48088547563009837,Upregulated
Feature0287,"(1S,2S,3R,4S,5R,6S)-2,3,4,6-Tetrahydroxy-5-methoxycyclohexyl 6-O-alpha-D-galactopyranosyl-alpha-D-galactopyranoside",C19 H34 O16,518.18462,NA,NA,"(1S,2S,3R,4S,5R,6S)-2,3,4,6-Tetrahydroxy-5-methoxycyclohexyl 6-O-alpha-D-galactopyranosyl-alpha-D-galactopyranoside",19,34,0,16,0,0,0,0,1.7894736842105263,0.8421052631578947,-0.10526315789473716,63.3,3,-13,-4.333333333333333,-0.4545454545454546,-13,Carbohydrate,114085.84174464093,220428.85785064165,1.932131581621048,0.9501933476354132,0.08929269958102093,0.28085732573866523,Upregulated
Feature0286,(-)-Shikimic acid,C7 H10 O5,174.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Other,(-)-Shikimic acid-peak2,7,10,0,5,0,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,927468.2663929173,713673.502490723,0.7694856291593904,-0.3780337117179976,0.49932803534109527,0.6228456295548732,Downregulated
Feature0285,"2,3-Dihydroxypropyl beta-D-galactopyranoside",C9 H18 O8,254.10022,Galactose metabolism;Other,NA,"2,3-Dihydroxypropyl beta-D-galactopyranoside",9,18,0,8,0,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,4722665.87058022,466791.700463199,0.09884072116366972,-3.3387506528488773,0.017392205901354926,0.20510808338839256,Downregulated
Feature0284,NA,C31 H27 N2 O10 P,618.14042,NA,NA,Feature0284,31,27,2,10,0,1,0,0,0.8709677419354839,0.3225806451612903,-0.193548387096774,65.81612903225806,20,10,0.3888888888888889,0.5217391304347826,7,Lignin,30160.339919445836,68139.9149068465,2.259255535210775,1.175847457332055,0.11921156205137699,0.2891514483799357,Upregulated
Feature0283,NA,C2 H5 N O4 S4,234.91002,NA,NA,Feature0283,2,5,1,4,4,0,0,0,2.5,2,7,-139.2,1,-3,1.1428571428571428,1.2,-8,Other,148053.0698634783,235196.642489658,1.5885968639929988,0.6677530604271075,0.12826490881691802,0.30045615626976685,Upregulated
Feature0282,D-Glucono-delta-lactone,C6 H10 O6,178.04779,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Galactose metabolism;Carbon metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,D-Glucono-delta-lactone-peak2,6,10,0,6,0,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,2932428.9543203874,1116791.6200865754,0.3808418336755239,-1.3927361343052134,0.3341848650354465,0.48224145081064423,Downregulated
Feature0281,NA,C12 H10 N2 O7 S,326.02086,NA,NA,Feature0281,12,10,2,7,1,0,0,0,0.8333333333333334,0.5833333333333334,1,31.799999999999997,9,2,-0.5,0.4545454545454546,-1,Lignin,2886633.087695404,1967505.6273552442,0.681591864148567,-0.5530199800139991,0.6996691465411535,0.7923405566790547,Downregulated
Feature0280,NA,C17 H33 N O8 S2,443.16496,NA,NA,Feature0280,17,33,1,8,2,0,0,0,1.9411764705882353,0.4705882352941176,-0.5882352941176467,77.06470588235292,2,-6,-1.5,-0.5,-9,Protein,646260.7309730316,228669.87689454167,0.35383532672679757,-1.4988500017790491,0.041570020570939344,0.24912498754207058,Downregulated
Feature0279,NA,C16 H28 O14,444.14812,NA,NA,Feature0279,16,28,0,14,0,0,0,0,1.75,0.875,0,60.3,3,-11,-5.5,-0.4444444444444444,-11,Carbohydrate,136054.76428039547,144761.96369390367,1.06399775457744,0.08949510623063422,0.822046163969703,0.8727302805418299,Upregulated
Feature0278,Phloroacetophenone,C8 H8 O4,168.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Phloroacetophenone,8,8,0,4,0,0,0,0,1,0.5,0,60.3,5,1,0.25,0.5,1,Lignin,1230788.697231211,6048482.05871899,4.914313945460897,2.2969900256064375,3.23486463806418e-4,0.11063237062179496,Upregulated
Feature0277,Dodecyl sulfate,C12 H26 O4 S,266.15522,NA,NA,Dodecyl sulfate-peak1,12,26,0,4,1,0,0,0,2.1666666666666665,0.3333333333333333,-1.333333333333333,98.29999999999998,0,-4,-0.7142857142857143,-0.3333333333333333,-5,Protein,1263872.9658929268,4102293.2556313565,3.245811380048852,1.6985791647119153,0.1052623907221727,0.28085732573866523,Upregulated
Feature0276,2-(Benzoyloxy)-3-hydroxysuccinic acid,C11 H10 O7,254.04268,NA,NA,2-(Benzoyloxy)-3-hydroxysuccinic acid,11,10,0,7,0,0,0,0,0.9090909090909092,0.6363636363636364,0.36363636363636376,49.93636363636363,7,0,0,0.4666666666666667,0,Lignin,416885.5591521443,415127.964041458,0.9957839865831263,-0.006095279586702381,0.9915961142612164,0.9915961142612164,Downregulated
Feature0275,trans-Aconitic acid,C6 H6 O6,174.01637,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Other,Superpathway of betalain biosynthesis;Other,trans-Aconitic acid,6,6,0,6,0,0,0,0,1,1,1,31.799999999999997,4,-2,-Inf,0.3333333333333333,-2,Tannin,1096563.5950932098,1570337.538578047,1.4320533214898181,0.5180852113289578,0.7956178027129545,0.8610800269868052,Upregulated
Feature0274,NA,C50 H80 O5 P2 S,854.52014,NA,NA,Feature0274,50,80,0,5,1,2,0,0,1.6,0.1,-1.5599999999999996,104.76,12,7,0.09523809523809525,0.14606741573033707,4,Lipid,605285.2628935985,57268.36874655467,0.09461384946459818,-3.4018048107400927,0.18686802792965918,0.3462599380783044,Downregulated
Feature0273,leu-gln,C11 H21 N3 O4,259.15323,NA,NA,leu-gln-peak2,11,21,3,4,0,0,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,325191.30884040083,434136.4543197334,1.335018626013776,0.41685987035496425,0.6610321056904258,0.7661354472230908,Upregulated
Feature0272,"N-acetyl-LL-2,6-diaminopimelic acid",C9 H16 N2 O5,232.10586,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,"N-acetyl-LL-2,6-diaminopimelic acid",9,16,2,5,0,0,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,574832.6852666116,1809910.5385295267,3.14858668429767,1.654704386990685,0.048368473121323426,0.24912498754207058,Upregulated
Feature0271,NA,C11 H9 N S,187.04563,NA,NA,Feature0271,11,9,1,0,1,0,0,0,0.8181818181818182,0,-0.3636363636363633,70.66363636363636,8,8,0.6666666666666666,0.6666666666666666,6,Unsaturated HC,2557193.8757680636,3683137.9731848966,1.4403045494853812,0.5263738988737171,0.14268485230810668,0.30872903951326996,Upregulated
Feature0270,leu-gln,C11 H21 N3 O4,259.15324,NA,NA,leu-gln-peak1,11,21,3,4,0,0,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,817660.836268218,2209334.6241287165,2.7020183994772946,1.4340374987732454,0.004774468876554245,0.16328683557815518,Upregulated
Feature0269,Gly-Phe,C11 H14 N2 O3,222.10048,NA,NA,Gly-Phe,11,14,2,3,0,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Lignin,713927.4168880653,1200511.8286913696,1.6815600581978973,0.749800306736601,0.08101230256151841,0.2798606815761545,Upregulated
Feature0268,3-formylsalicylic acid,C8 H6 O4,166.02653,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate,3-formylsalicylic acid,8,6,0,4,0,0,0,0,0.75,0.5,0.25,53.175,6,2,0.5,0.6666666666666666,2,Condensed HC,1142611.4144399571,1211526.2099230627,1.0603134141775432,0.08449076879486866,0.8906636489620632,0.9258570454256098,Upregulated
Feature0267,NA,C9 H22 N O8 P,303.10844,NA,NA,Feature0267,9,22,1,8,0,1,0,0,2.4444444444444446,0.8888888888888888,-0.8888888888888893,85.63333333333334,0,-8,10,-2,-10,Carbohydrate,37388027.01121357,16613655.1906584,0.4443576331448451,-1.170206823987469,0.1430835180578064,0.30872903951326996,Downregulated
Feature0266,Gly-thr,C6 H12 N2 O4,176.0797,Other,NA,Gly-thr,6,12,2,4,0,0,0,0,2,0.6666666666666666,0.3333333333333335,50.8,2,-2,-Inf,-1,-4,Amino Sugar,579982.3698930154,1635450.1831483867,2.8198274086332398,1.4956068632166715,0.024638812830075046,0.22954141724043495,Upregulated
Feature0265,NA,C9 H24 N6 O P2,294.14866,NA,NA,Feature0265,9,24,6,1,0,2,0,0,2.6666666666666665,0.1111111111111111,-1.5555555555555554,104.63333333333333,2,1,-Inf,-13,-7,Other,1051939.5718544982,236794.33103519265,0.22510259844844535,-2.15134538439894,0.09363703978894455,0.28085732573866523,Downregulated
Feature0264,NA,C7 H17 N O10,275.08534,NA,NA,Feature0264,7,17,1,10,0,0,0,0,2.4285714285714284,1.4285714285714286,0.8571428571428572,35.87142857142857,0,-10,2.75,-6,-11,Carbohydrate,722368.2529761629,238357.60342032864,0.3299668866098329,-1.5996068429034684,0.0014091694052498242,0.1575263660575476,Downregulated
Feature0263,D-Glucosamine 6-phosphate,C6 H14 N O8 P,259.04576,Metabolic pathways;Biosynthesis of secondary metabolites;Galactose metabolism;Phosphotransferase system (PTS);Other,Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,D-Glucosamine 6-phosphate,6,14,1,8,0,1,0,0,2.3333333333333335,1.3333333333333333,0,60.3,1,-7,2.25,-Inf,-9,Carbohydrate,690845.9157738787,717203.955023745,1.0381532822993391,0.05401947191042491,0.8439742630264196,0.8881206090924171,Upregulated
Feature0262,Luteolin,C15 H10 O6,286.04782,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,Other,Luteolin,15,10,0,6,0,0,0,0,0.6666666666666666,0.4,0.1333333333333333,56.5,11,5,0.5555555555555556,0.6666666666666666,5,Condensed HC,30251.830529707033,76007.52168991251,2.5124933056620753,1.3291197523508729,0.006678709454731437,0.17570143334755012,Upregulated
Feature0261,NA,C7 H7 N3 O4 P2,258.99119,NA,NA,Feature0261,7,7,3,4,0,2,0,0,1,0.5714285714285714,0,60.3,7,3,1,NA,-2,Lignin,467006.2493762217,201244.81669417932,0.4309253183720372,-1.214490230561311,0.3412244826403022,0.4882793852007672,Downregulated
Feature0260,Abietin,C16 H22 O8,342.13151,Biosynthesis of secondary metabolites;Other,NA,Abietin,16,22,0,8,0,0,0,0,1.375,0.5,-0.375,70.9875,6,-2,-0.25,0.16666666666666666,-2,Lignin,79760.60326848106,110102.26483374016,1.3804091283402966,0.4650959191408722,0.14925515210431442,0.3131611166851259,Upregulated
Feature0259,2-Aminomuconic acid,C6 H7 N O4,157.03757,Metabolic pathways;Other,Other,2-Aminomuconic acid,6,7,1,4,0,0,0,0,1.1666666666666667,0.6666666666666666,0.6666666666666665,41.3,4,0,-1,0.3333333333333333,-1,Tannin,897734.6886840783,1383979.05602397,1.5416348209209123,0.6244610632814137,0.043151598713712706,0.24912498754207058,Upregulated
Feature0258,3653579,C18 H24 O5,320.16251,NA,NA,3653579,18,24,0,5,0,0,0,0,1.3333333333333333,0.2777777777777778,-0.7777777777777777,82.46666666666667,7,2,0.15384615384615383,0.2903225806451613,2,Lignin,391061.7928536833,12756921.07228947,32.62124120896286,5.027739771233542,0.10372432629444511,0.28085732573866523,Upregulated
Feature0257,"2-Hydroxy-3,4,5-trimethoxybenzoic acid",C10 H12 O6,228.06339,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"2-Hydroxy-3,4,5-trimethoxybenzoic acid",10,12,0,6,0,0,0,0,1.2,0.6,0,60.3,5,-1,-0.25,0.2857142857142857,-1,Lignin,477923.2955118883,909007.9934134206,1.9019955753356015,0.9275138900213942,0.4892874458960181,0.6174771457433144,Upregulated
Feature0256,NA,C14 H22 O10,350.12144,NA,NA,Feature0256,14,22,0,10,0,0,0,0,1.5714285714285714,0.7142857142857143,-0.14285714285714324,64.37142857142858,4,-6,-1.5,-0.1111111111111111,-6,Carbohydrate,686370.7253930203,182837.36447224932,0.2663828128269245,-1.9084270929934537,0.23129819413885933,0.3784879540454062,Downregulated
Feature0255,Troxipide,C15 H22 N2 O4,294.1581,NA,NA,Troxipide,15,22,2,4,0,0,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,674141.8284049353,1780998.95489692,2.641875759453886,1.401562621984319,0.012144700131982005,0.20510808338839256,Upregulated
Feature0254,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,C14 H16 N2 O5,292.10606,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,14,16,2,5,0,0,0,0,1.1428571428571428,0.35714285714285715,0,60.3,8,3,0.14285714285714285,0.3684210526315789,1,Lignin,71322.40658451493,125854.45070075987,1.7645850263286629,0.8193289478888529,0.11017611621374537,0.2809171845669831,Upregulated
Feature0253,NA,C11 H20 N4 O3,256.15361,NA,NA,Feature0253,11,20,4,3,0,0,0,0,1.818181818181818,0.2727272727272727,-0.18181818181818168,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,95727.07956786294,161660.82762149634,1.6887679886535303,0.7559711371323186,0.11170447399579421,0.2809171845669831,Upregulated
Feature0252,MFCD00037215,C8 H14 N2 O5,218.09029,NA,NA,MFCD00037215,8,14,2,5,0,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,670122.066296268,1227440.1268823396,1.8316664808045215,0.8731568340607705,0.15549335243402002,0.32035377429177614,Upregulated
Feature0251,N-Acetyl-4-aminosalicylic acid,C9 H9 N O4,195.05319,Metabolic pathways;Microbial metabolism in diverse environments;Other,Superpathway of betalain biosynthesis,N-Acetyl-4-aminosalicylic acid,9,9,1,4,0,0,0,0,1,0.4444444444444444,0.22222222222222232,53.96666666666666,6,2,0.25,0.5,1,Lignin,2554895.0326877134,1305940.52841896,0.5111523219977961,-0.9681748204671053,0.06494977186588544,0.27718515590669207,Downregulated
Feature0250,NA,C12 H19 N O8,305.11118,NA,NA,Feature0250,12,19,1,8,0,0,0,0,1.5833333333333333,0.6666666666666666,0,60.3,4,-4,-1.6666666666666667,-0.14285714285714285,-5,Amino Sugar,1239758.1654949854,1689090.7696051,1.3624356883592004,0.4461881313390796,0.3621242054045656,0.5117623068114109,Upregulated
Feature0249,"10,16-Dihydroxyhexadecanoic acid",C16 H32 O4,288.23015,Other,NA,"10,16-Dihydroxyhexadecanoic acid",16,32,0,4,0,0,0,0,2,0.25,-1.5,103.05,1,-3,-0.25,-0.07142857142857142,-3,Lipid,38432.84192946243,71675.90913579089,1.8649651063364243,0.8991486377800639,0.09264887845111136,0.28085732573866523,Upregulated
Feature0248,"1-(3-Methoxyphenyl)-2,3-butanedione",C11 H12 O3,192.07867,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,"1-(3-Methoxyphenyl)-2,3-butanedione",11,12,0,3,0,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,134212.02696673613,111978.98116679133,0.8343438639410821,-0.2612860007140472,0.5741675317477521,0.6938703033842093,Downregulated
Feature0247,NA,C28 H41 N O6,487.29353,NA,NA,Feature0247,28,41,1,6,0,0,0,0,1.4642857142857142,0.21428571428571427,-0.9285714285714288,86.76428571428572,9,3,0.09523809523809525,0.20833333333333337,2,Lignin,33059.60310843883,64111.2201967683,1.9392616416620925,0.9555074623738031,0.0724528253320487,0.2798606815761545,Upregulated
Feature0246,"9-Hydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-7H-furo[3,2-g]chromen-7-one",C14 H14 O5,262.08415,NA,NA,"9-Hydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-7H-furo[3,2-g]chromen-7-one",14,14,0,5,0,0,0,0,1,0.35714285714285715,-0.2857142857142856,68.44285714285714,8,3,0.3333333333333333,0.4782608695652174,3,Lignin,25849.67484964007,51145.74312753724,1.9785836156561711,0.984468035410937,0.04471488495078743,0.24912498754207058,Upregulated
Feature0245,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid,C9 H8 O6 S,244.00421,NA,NA,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid-peak2,9,8,0,6,1,0,0,0,0.8888888888888888,0.6666666666666666,0.6666666666666665,41.3,6,0,-0.5,0.4,-1,Tannin,47408.050330572136,75448.7619115737,1.5914757385185885,0.6703651637688628,0.11042689979012324,0.2809171845669831,Upregulated
Feature0244,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",C14 H23 N O3,253.16783,NA,NA,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",14,23,1,3,0,0,0,0,1.6428571428571428,0.21428571428571427,-1,88.8,4,1,0,0.13043478260869565,0,Lipid,38043.998972148765,71392.27669735426,1.876571302339144,0.9080991080116094,0.064821052420059,0.27718515590669207,Upregulated
Feature0243,NA,C7 H17 N8 O6 P,340.10075,Other,NA,Feature0243,7,17,8,6,0,1,0,0,2.4285714285714284,0.8571428571428571,2,3.299999999999997,4,-2,1.375,1.6,-11,Carbohydrate,497004.664450068,372539.79103554465,0.7495700094641107,-0.4158648634256905,0.6710664696036733,0.7727432074224118,Downregulated
Feature0242,NA,C4 H10 N6 P2,204.04415,NA,NA,Feature0242,4,10,6,0,0,2,0,0,2.5,0,-0.5,74.55,4,4,1,1,-4,Lipid,1389780.8443503527,1517150.7067666666,1.0916474442240944,0.1265070022342136,0.8034969137055817,0.8641381902116634,Upregulated
Feature0241,"(2E)-3-(4,5-Dihydroxy-2,3-dimethoxyphenyl)-2-propen-1-yl hydrogen sulfate",C11 H14 O8 S,306.04103,NA,NA,"(2E)-3-(4,5-Dihydroxy-2,3-dimethoxyphenyl)-2-propen-1-yl hydrogen sulfate",11,14,0,8,1,0,0,0,1.2727272727272727,0.7272727272727273,0.36363636363636376,49.93636363636363,5,-3,-2,0,-4,Tannin,34841.7042438758,62076.49164730214,1.7816720793218217,0.8332318300864743,0.076830006988072,0.2798606815761545,Upregulated
Feature0240,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10623,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine,8,15,3,4,0,0,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,253242.09655541833,385629.79148040165,1.5227712798374033,0.6066992653812883,0.02483109569494132,0.22954141724043495,Upregulated
Feature0239,Catechin,C15 H14 O6,290.07918,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,NA,Catechin,15,14,0,6,0,0,0,0,0.9333333333333332,0.4,-0.13333333333333375,64.10000000000001,9,3,0.3333333333333333,0.5,3,Lignin,907874.6683980707,1196499.6264807796,1.3179127781943543,0.39825489338819176,0.17035161326076764,0.33291572420104304,Upregulated
Feature0238,NA,C30 H50 O6 S,538.3329,NA,NA,Feature0238,30,50,0,6,1,0,0,0,1.6666666666666667,0.2,-1.2000000000000002,94.5,6,0,-0.04347826086956521,0.07692307692307693,-1,Lipid,949706.5428156109,411756.24761677464,0.4335615572322309,-1.205691252515562,0.6039117483048871,0.7172759172773918,Downregulated
Feature0237,MFCD00155202,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,MFCD00155202-peak2,10,12,0,4,0,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Lignin,522915.65584272245,4462716.073733044,8.534294247780748,3.093271853039119,0.010602417702326823,0.20510808338839256,Upregulated
Feature0236,pseudouridine,C9 H12 N2 O6,244.06949,Metabolic pathways;ABC transporters;Other,Other,pseudouridine,9,12,2,6,0,0,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,319875.76746752235,293575.44074033375,0.9177795588099404,-0.12378042011793307,0.8983282786122192,0.9309947614708454,Downregulated
Feature0235,"(6E,8R,10Z)-8-Hydroxy-3-oxo-6,10-hexadecadienoic acid",C16 H26 O4,282.18315,Other,NA,"(6E,8R,10Z)-8-Hydroxy-3-oxo-6,10-hexadecadienoic acid",16,26,0,4,0,0,0,0,1.625,0.25,-1.125,92.3625,4,0,0,0.14285714285714285,0,Lipid,457260.50541390554,4315589.005716097,9.437922047979386,3.2384692556601764,0.08227624993069518,0.28085732573866523,Upregulated
Feature0234,"2,4,6-Trihydroxyacetophenone",C8 H8 O4,168.0422,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"2,4,6-Trihydroxyacetophenone-peak2",8,8,0,4,0,0,0,0,1,0.5,0,60.3,5,1,0.25,0.5,1,Lignin,437654.02695870004,3872582.4893521266,8.848501900606456,3.1454332197701595,0.0027910174031315475,0.1590879919784982,Upregulated
Feature0233,NA,C12 H15 N3 O9 P2,407.02843,NA,NA,Feature0233,12,15,3,9,0,2,0,0,1.25,0.75,0.16666666666666652,55.55,8,-1,3,-0.6,-6,Tannin,947473.6505325333,184227.47557975774,0.19444073771994774,-2.3625975819653915,0.012952991665771336,0.20510808338839256,Downregulated
Feature0232,cis-trihomoaconitic acid,C9 H12 O6,216.06335,Metabolic pathways;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Other,NA,cis-trihomoaconitic acid-peak1,9,12,0,6,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,4,-2,-0.6666666666666666,0.16666666666666666,-2,Tannin,1705039.33666537,1215528.7882914857,0.7129036627792739,-0.48822096158560035,0.23078376139590945,0.3784879540454062,Downregulated
Feature0231,Pyrogallol,C6 H6 O3,126.03174,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,Pyrogallol,6,6,0,3,0,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,1465727.6175594206,4199546.22302257,2.8651614206568774,1.5186164214327569,0.05099049452615479,0.24912498754207058,Upregulated
Feature0230,NA,C27 H37 N O7,487.25721,NA,NA,Feature0230,27,37,1,7,0,0,0,0,1.3703703703703705,0.25925925925925924,-0.7407407407407405,81.4111111111111,10,3,0.10526315789473684,0.24444444444444444,2,Lignin,43922.83787504563,69798.670512137,1.589120236508955,0.6682282864565207,0.01184651458423856,0.20510808338839256,Upregulated
Feature0229,NA,C10 H20 O9,284.11082,NA,NA,Feature0229,10,20,0,9,0,0,0,0,2,0.9,-0.20000000000000015,66,1,-8,-8,-0.6363636363636364,-8,Carbohydrate,278558.3582768857,541555.7734923007,1.9441375833856571,0.9591303196867988,0.226216273407438,0.37556293934632906,Upregulated
Feature0228,5-Aminonicotinic acid,C6 H6 N2 O2,138.04298,Metabolic pathways;Other,NA,5-Aminonicotinic acid,6,6,2,2,0,0,0,0,1,0.3333333333333333,0.6666666666666665,41.3,5,3,0.5,0.6666666666666666,1,Lignin,374988.271873685,3880549.6943795835,10.348456166348447,3.3713436503140715,0.0656491158726376,0.27718515590669207,Upregulated
Feature0227,NA,C27 H37 N O6,471.26226,NA,NA,Feature0227,27,37,1,6,0,0,0,0,1.3703703703703705,0.2222222222222222,-0.8148148148148149,83.52222222222223,10,4,0.15,0.2608695652173913,3,Lignin,34395.279797341165,60127.15035343137,1.748122146634764,0.8058059938702992,0.0671264619833405,0.2774530470920791,Upregulated
Feature0226,2-[3-carboxylato-3-(methylammonio)propyl]-L-histidine dizwitterion,C11 H18 N4 O4,270.13292,NA,NA,2-[3-carboxylato-3-(methylammonio)propyl]-L-histidine dizwitterion,11,18,4,4,0,0,0,0,1.6363636363636365,0.3636363636363637,0.18181818181818168,55.11818181818182,5,1,-1,-0.2,-3,Protein,702505.6107092707,710093.7685884687,1.010801561956974,0.015499798744197152,0.9663919106498837,0.9821555262770645,Upregulated
Feature0225,UNII:74D1OHC38H,C19 H32 O4,324.23021,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H,19,32,0,4,0,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,52369.510682567,658377.2405843224,12.571766128864862,3.6521154340945703,0.013819965548728176,0.20510808338839256,Upregulated
Feature0224,val-phe,C14 H20 N2 O3,264.14747,Metabolic pathways;Other,NA,val-phe,14,20,2,3,0,0,0,0,1.4285714285714286,0.21428571428571427,-0.5714285714285712,76.58571428571427,6,3,0.1111111111111111,0.23809523809523808,1,Lignin,146872.87216073167,730574.1638463864,4.9741940298333365,2.314462784277516,0.09517611366503069,0.28085732573866523,Upregulated
Feature0223,(-)-Shikimic acid,C7 H10 O5,174.05282,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Other,(-)-Shikimic acid-peak1,7,10,0,5,0,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,718855.504742701,287240.75856515166,0.399580662135937,-1.3234413298642809,0.01949447080407747,0.20834715671857798,Downregulated
Feature0222,NP-008177,C28 H41 N O5,471.29858,NA,NA,NP-008177,28,41,1,5,0,0,0,0,1.4642857142857142,0.17857142857142858,-1,88.8,9,4,0.13636363636363635,0.22448979591836735,3,Lignin,60541.1148559737,114819.21359779507,1.896549375923256,0.9233769321237574,0.04594957315400434,0.24912498754207058,Upregulated
Feature0221,D-(-)-Mannitol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Galactose metabolism;Fructose and mannose metabolism;Phosphotransferase system (PTS);Other,Other,D-(-)-Mannitol,6,14,0,6,0,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,3120962.3653022265,2599675.827671907,0.8329725012304532,-0.2636592259391521,0.3653625872811151,0.5142140117289768,Downregulated
Feature0220,2271703,C10 H17 N O5,231.11056,NA,NA,2271703,10,17,1,5,0,0,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,736431.5955622654,549006.770342291,0.7454959478254385,-0.4237275841868713,0.39164062054326537,0.5336298495051663,Downregulated
Feature0219,2-Hydroxybenzyl alcohol,C7 H8 O2,124.05246,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,2-Hydroxybenzyl alcohol,7,8,0,2,0,0,0,0,1.1428571428571428,0.2857142857142857,-0.5714285714285712,76.58571428571427,4,2,0.4,0.5,2,Lignin,2172694.921619365,171893.74996436434,0.07911545622624622,-3.659896618431239,0.22101414041680548,0.3723489459238792,Downregulated
Feature0218,2'-Deoxyinosine,C10 H12 N4 O4,252.08587,Metabolic pathways;ABC transporters;Other,Other,2'-Deoxyinosine,10,12,4,4,0,0,0,0,1.2,0.4,0.7999999999999998,37.5,7,3,-0.5,0.25,-1,Lignin,346971.023832898,220163.65976309002,0.6345303919935439,-0.6562388286487187,0.05513470846832294,0.2583023328241979,Downregulated
Feature0217,S-inosyl-L-homocysteine,C14 H19 N5 O6 S,385.10554,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,S-inosyl-L-homocysteine,14,19,5,6,1,0,0,0,1.3571428571428572,0.42857142857142855,0.7142857142857144,39.942857142857136,8,2,-2,-0.2,-4,Lignin,105928.33947001646,198948.65200019034,1.878143780933182,0.9093075124587342,0.08733660981745438,0.28085732573866523,Upregulated
Feature0216,asp-leu,C10 H18 N2 O5,246.12157,Metabolic pathways;Other,NA,asp-leu-peak1,10,18,2,5,0,0,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,320625.4187615573,613970.4617995044,1.9149151186172855,0.9372804440228544,0.10136693886961733,0.28085732573866523,Upregulated
Feature0215,lys-leu,C12 H25 N3 O3,259.18964,NA,NA,lys-leu,12,25,3,3,0,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,362000.53920173633,242155.390480567,0.668936546377955,-0.5800587279182942,0.43737932707624627,0.5753220379233701,Downregulated
Feature0214,2-Aminooctanedioic acid,C8 H15 N O4,189.10013,NA,NA,2-Aminooctanedioic acid-peak2,8,15,1,4,0,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,2041436.4644626733,1138259.109203145,0.5575775337699507,-0.842755662396325,0.13544777329671526,0.30872903951326996,Downregulated
Feature0213,beta-D-Xylopyranosyl-(1->4)-beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranose,C20 H34 O17,546.17964,ABC transporters,NA,beta-D-Xylopyranosyl-(1->4)-beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranose,20,34,0,17,0,0,0,0,1.7,0.85,0,60.3,4,-13,-4.333333333333333,-0.391304347826087,-13,Carbohydrate,285172.566283118,534267.50658968,1.8734884408876193,0.9057270765058023,0.18391727598465604,0.3462599380783044,Upregulated
Feature0212,N-Acetylalanine,C5 H9 N O3,131.05829,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;Other,Other,N-Acetylalanine,5,9,1,3,0,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,1188237.4512182034,1266215.86861278,1.0656252816426814,0.09170021543834314,0.7503489233553453,0.8345694739566754,Upregulated
Feature0211,Threonylleucine,C10 H20 N2 O4,232.14232,Other,NA,Threonylleucine,10,20,2,4,0,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,958684.0929377624,1882990.27990345,1.9641405273902812,0.973898153133406,0.08874002232257322,0.28085732573866523,Upregulated
Feature0210,2-Hydroxy-3-[4-(sulfooxy)phenyl]propanoic acid,C9 H10 O7 S,262.01468,NA,NA,2-Hydroxy-3-[4-(sulfooxy)phenyl]propanoic acid,9,10,0,7,1,0,0,0,1.1111111111111112,0.7777777777777778,0.6666666666666665,41.3,5,-2,-3,0.1111111111111111,-3,Tannin,873614.7517102023,543243.0705553531,0.6218336738154795,-0.6853993506252637,0.18659351918622544,0.3462599380783044,Downregulated
Feature0209,3-[(2Z)-1-Oxo-2-buten-2-yl]pentanedioic acid,C9 H12 O5,200.06848,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,3-[(2Z)-1-Oxo-2-buten-2-yl]pentanedioic acid-peak2,9,12,0,5,0,0,0,0,1.3333333333333333,0.5555555555555556,-0.22222222222222232,66.63333333333333,4,-1,-0.25,0.2307692307692308,-1,Lignin,105688.5746967076,211228.44712868633,1.9985930147591109,0.9989847175214301,0.09808229624557631,0.28085732573866523,Upregulated
Feature0208,Loganetin,C11 H16 O5,228.09967,NA,NA,Loganetin,11,16,0,5,0,0,0,0,1.4545454545454546,0.4545454545454546,-0.5454545454545459,75.84545454545456,4,-1,-0.16666666666666666,0.17647058823529413,-1,Lignin,89520.7393670593,1201668.401361172,13.423352061850226,3.7466730793269227,0.41430598308491534,0.5515742399361392,Upregulated
Feature0207,3-Hydroxybutyric acid,C4 H8 O3,104.04737,Metabolic pathways;Microbial metabolism in diverse environments;Carbon metabolism;Other,NA,3-Hydroxybutyric acid-peak2,4,8,0,3,0,0,0,0,2,0.75,-0.5,74.55,1,-2,-2,-0.2,-2,Carbohydrate,621278.9734683867,557493.340553198,0.8973317372080123,-0.1562866569588102,0.8240841462060496,0.8727302805418299,Downregulated
Feature0206,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.09571,Other,NA,N-(2-Cyanoethyl)-L-glutamine,8,13,3,3,0,0,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,3081777.031123675,5805510.996694737,1.8838192828564033,0.913660572046208,0.24611778526469213,0.3914989886536033,Upregulated
Feature0205,NA,C6 H3 N2 O4 P3,259.93046,NA,NA,Feature0205,6,3,2,4,0,3,0,0,0.5,0.6666666666666666,-0.666666666666667,79.30000000000001,8,4,0.3333333333333333,-1,-1,Condensed HC,716263.831812429,1247059.638526892,1.741061858968002,0.799967462059068,0.1855073827939142,0.3462599380783044,Upregulated
Feature0204,Miglitol,C8 H17 N O5,207.11059,NA,NA,Miglitol,8,17,1,5,0,0,0,0,2.125,0.625,-0.5,74.55,1,-4,-2.5,-0.5555555555555556,-5,Amino Sugar,3892617.39977197,4074975.790244283,1.0468472422907515,0.06605093714157542,0.6630879894094587,0.7661354472230908,Upregulated
Feature0203,Cystathionine,C7 H14 N2 O4 S,222.06744,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;Other,Other,Cystathionine,7,14,2,4,1,0,0,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,2288777.1992493835,3401910.2151531,1.4863439815237474,0.5717680344564366,0.1843935653148045,0.3462599380783044,Upregulated
Feature0202,methylguanosine,C11 H15 N5 O5,297.10742,NA,NA,methylguanosine,11,15,5,5,0,0,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,3224465.4580115336,3500060.05589851,1.0854698558492017,0.11831966200029995,0.7866186624909021,0.8540431192758364,Upregulated
Feature0201,melizame,C7 H6 N4 O2,178.04906,NA,NA,melizame,7,6,4,2,0,0,0,0,0.8571428571428571,0.2857142857142857,1.4285714285714284,19.58571428571429,7,5,1,1,1,Lignin,210539.3135431593,308561.17601280665,1.4655751024359327,0.5514668998839343,0.061398427435054324,0.2762929234577445,Upregulated
Feature0200,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11117,NA,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,13085806.052748464,12854040.08370862,0.9822887510249194,-0.025780917152517596,0.9764119267081928,0.9821555262770645,Downregulated
Feature0199,"1,5-Anhydro-D-glucitol",C6 H12 O5,164.06849,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Fructose and mannose metabolism;Other,Other,"1,5-Anhydro-D-glucitol",6,12,0,5,0,0,0,0,2,0.8333333333333334,-0.33333333333333304,69.79999999999998,1,-4,-4,-0.42857142857142855,-4,Carbohydrate,334431.190976895,320803.67219287466,0.9592516513061672,-0.060018751526150424,0.8242452649561727,0.8727302805418299,Downregulated
Feature0198,NA,C7 H6 N4 O5 P2,287.98122,NA,NA,Feature0198,7,6,4,5,0,2,0,0,0.8571428571428571,0.7142857142857143,0.8571428571428572,35.87142857142857,8,3,0.75,0.3333333333333333,-3,Tannin,3108793.587167537,5331531.549480656,1.71498409270018,0.7781951947718503,0.10824142904320343,0.2809171845669831,Upregulated
Feature0197,NA,C18 H28 O15,484.143,NA,NA,Feature0197,18,28,0,15,0,0,0,0,1.5555555555555556,0.8333333333333334,0.11111111111111116,57.133333333333326,5,-10,-3.3333333333333335,-0.23809523809523808,-10,Carbohydrate,69313.90684884714,132109.27952151507,1.9059563300854736,0.93051506411098,0.10337408269289793,0.28085732573866523,Upregulated
Feature0196,NA,C31 H34 O11,582.21017,NA,NA,Feature0196,31,34,0,11,0,0,0,0,1.096774193548387,0.3548387096774194,-0.387096774193548,71.33225806451611,15,4,0.2,0.37254901960784315,4,Lignin,62777.59801254667,102638.14672627936,1.6349486118561944,0.7092452910228534,0.06733509622410107,0.2774530470920791,Upregulated
Feature0195,NA,C11 H23 N O7,281.14757,NA,NA,Feature0195,11,23,1,7,0,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,104995.36165355484,177832.62922759,1.693718907453938,0.7601944623491703,0.1435319218789764,0.30872903951326996,Upregulated
Feature0194,Glu-Gly,C7 H12 N2 O5,204.07461,NA,NA,Glu-Gly,7,12,2,5,0,0,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,1074507.1804884907,2278334.37221462,2.120352859046365,1.0843043712203781,0.41753834533731154,0.5534810624238781,Upregulated
Feature0193,NA,C6 H14 O7,198.07397,NA,NA,Feature0193,6,14,0,7,0,0,0,0,2.3333333333333335,1.1666666666666667,0,60.3,0,-7,7,-1.4,-7,Carbohydrate,164681268.57115465,139935022.56986225,0.8497324788908814,-0.23491938554947212,0.5701857650349442,0.6915018852551452,Downregulated
Feature0192,Glycolic acid,C2 H4 O3,76.01606,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Other,Other,Glycolic acid-peak1,2,4,0,3,0,0,0,0,2,1.5,1,31.799999999999997,1,-2,2,-1,-2,Carbohydrate,2998536.8595399,2603426.906778653,0.8682324175858644,-0.20384680473466868,0.7268241977991012,0.8149963135976808,Downregulated
Feature0191,L-glycero-ÃÂ±-D-manno-Heptopyranose,C7 H14 O7,210.07387,Metabolic pathways;Other,NA,L-glycero-ÃÂ±-D-manno-Heptopyranose,7,14,0,7,0,0,0,0,2,1,0,60.3,1,-6,-Inf,-0.7142857142857143,-6,Carbohydrate,352056.3030493673,841029.038504426,2.3889049314549333,1.2563494416353604,0.2114079766744473,0.3633242614204069,Upregulated
Feature0190,NP-001596,C16 H30 O4,286.21438,Metabolic pathways;Other,NA,NP-001596,16,30,0,4,0,0,0,0,1.875,0.25,-1.375,99.4875,2,-2,-0.16666666666666666,0,-2,Lipid,41771.86588742454,294040.53828661965,7.039200477159936,2.815411574723334,0.01683951731254084,0.20510808338839256,Upregulated
Feature0189,3-Hydroxybutyric acid,C4 H8 O3,104.04736,Metabolic pathways;Microbial metabolism in diverse environments;Carbon metabolism;Other,NA,3-Hydroxybutyric acid-peak1,4,8,0,3,0,0,0,0,2,0.75,-0.5,74.55,1,-2,-2,-0.2,-2,Carbohydrate,599335.214483771,766356.7486508853,1.2786779920999236,0.3546529978471163,0.30224424958775264,0.4513866085546349,Upregulated
Feature0188,(2S)-5-Carbamimidamido-2-(2-oxo-1-azetidinyl)pentanoic acid,C9 H16 N4 O3,228.12222,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,(2S)-5-Carbamimidamido-2-(2-oxo-1-azetidinyl)pentanoic acid,9,16,4,3,0,0,0,0,1.7777777777777777,0.3333333333333333,0.22222222222222232,53.96666666666666,4,1,-1.5,-0.42857142857142855,-3,Protein,1879613.82951292,2365707.933090957,1.2586138152133104,0.33183568389606777,0.22060151796776944,0.3723489459238792,Upregulated
Feature0187,2'-O-Methylinosine,C11 H14 N4 O5,282.09642,ABC transporters,NA,2'-O-Methylinosine,11,14,4,5,0,0,0,0,1.2727272727272727,0.4545454545454546,0.7272727272727271,39.57272727272728,7,2,-1,0.1111111111111111,-2,Lignin,111529.29603271741,184816.742195648,1.6571138594959975,0.7286727328471355,0.15132634613120213,0.3136582447083099,Upregulated
Feature0186,NP-011548,C18 H34 O3,298.25084,Other,NA,NP-011548,18,34,0,3,0,0,0,0,1.8888888888888888,0.16666666666666666,-1.5555555555555554,104.63333333333333,2,-1,-0.06666666666666667,0.0303030303030303,-1,Lipid,240979.01052871565,339433.82149264234,1.4085617695413126,0.4942228314848943,0.11565701254385857,0.28618335204303436,Upregulated
Feature0185,4-Dodecylbenzenesulfonic acid,C18 H30 O3 S,326.19169,NA,NA,4-Dodecylbenzenesulfonic acid,18,30,0,3,1,0,0,0,1.6666666666666667,0.16666666666666666,-1.2222222222222223,95.13333333333333,4,1,0,0.0967741935483871,0,Lipid,793888.1144173658,2366750.3783651297,2.981214021703911,1.575899950292974,0.30392395496337654,0.4519217069455425,Upregulated
Feature0184,NA,C7 H18 N O7 P,259.0822,NA,NA,Feature0184,7,18,1,7,0,1,0,0,2.5714285714285716,1,-0.8571428571428568,84.72857142857141,0,-7,4.5,-3.6666666666666665,-9,Other,1179016.2488384454,518119.40244996204,0.43945060380669726,-1.1862270857146808,0.03377160077173022,0.2406226554985778,Downregulated
Feature0183,Valylvaline,C10 H20 N2 O3,216.1473,NA,NA,Valylvaline,10,20,2,3,0,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.2307692307692308,-3,Lipid,474796.45328415,1879190.30197127,3.957886140414441,1.9847301098532912,0.027034539009843876,0.22954141724043495,Upregulated
Feature0182,NA,C30 H52 O6 S,540.34851,NA,NA,Feature0182,30,52,0,6,1,0,0,0,1.7333333333333334,0.2,-1.2666666666666666,96.4,5,-1,-0.08695652173913043,0.03846153846153846,-2,Lipid,3300897.98563841,1087007.6146322563,0.3293066369701891,-1.6024965060409913,0.04963596189443139,0.24912498754207058,Downregulated
Feature0181,"Î±,Î±-Trehalose",C12 H22 O11,342.11625,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,"Î±,Î±-Trehalose-peak3",12,22,0,11,0,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,386012.00235744234,979280.777197498,2.5369179487084863,1.3430768592104292,0.49784638275670584,0.6228456295548732,Upregulated
Feature0180,Adenosine 5'-monophosphate,C10 H14 N5 O7 P,347.06322,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of plant hormones;Other,Superpathway of anaerobic sucrose degradation;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of purine nucleotide salvage;Superpathway of chorismate metabolism;Other,Adenosine 5'-monophosphate,10,14,5,7,0,1,0,0,1.4,0.7,1,31.799999999999997,7,0,2,-5,-6,Tannin,104947.79642411886,185641.31738126132,1.7688919987518448,0.8228459657097326,0.13853037932020065,0.30872903951326996,Upregulated
Feature0179,16-Hydroxyhexadecanoic acid,C16 H32 O3,272.23521,Metabolic pathways;Other,NA,16-Hydroxyhexadecanoic acid,16,32,0,3,0,0,0,0,2,0.1875,-1.625,106.6125,1,-2,-0.15384615384615383,-0.03448275862068965,-2,Lipid,364513.40895765164,194760.66765063326,0.5343031637918706,-0.9042695350103569,0.2019138478142265,0.35779552306976925,Downregulated
Feature0178,Sorbic acid,C6 H8 O2,112.05247,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Sorbic acid,6,8,0,2,0,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Lignin,331524.88212196267,322517.7786431023,0.9728312897022711,-0.03973846317377685,0.9418848368653309,0.967341183807637,Downregulated
Feature0177,4-Undecylbenzenesulfonic acid,C17 H28 O3 S,312.17592,NA,NA,4-Undecylbenzenesulfonic acid-peak1,17,28,0,3,1,0,0,0,1.6470588235294117,0.17647058823529413,-1.1764705882352944,93.8294117647059,4,1,0,0.10344827586206896,0,Lipid,844654.845591346,1655982.98900675,1.9605439993035145,0.9712540197502857,0.07634102459703103,0.2798606815761545,Upregulated
Feature0176,4-Carboxy-2-[(5-oxidanidyl-5-oxidanylidenenorvalyl)amino]butanoate,C10 H14 N2 O7,274.08009,NA,NA,4-Carboxy-2-[(5-oxidanidyl-5-oxidanylidenenorvalyl)amino]butanoate,10,14,2,7,0,0,0,0,1.4,0.7,0.6000000000000001,43.2,5,-2,-4,-0.1111111111111111,-4,Tannin,14446094.4736093,13499354.048737666,0.9344639184935986,-0.09778913516016724,0.6949254315317361,0.7922149919461792,Downregulated
Feature0175,Guanine,C5 H5 N5 O,151.04944,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine,5,5,5,1,0,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,200600.30721863848,263541.24317710067,1.3137629090959544,0.3937049402462289,0.6507642905542828,0.7595951787357157,Upregulated
Feature0174,N-Acetyl-L-methionine,C7 H13 N O3 S,191.0616,NA,NA,N-Acetyl-L-methionine,7,13,1,3,1,0,0,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,167670.81306143635,217008.16014714868,1.2942512544961216,0.37211771657972215,0.1507149589765837,0.3136582447083099,Upregulated
Feature0173,Pyrrole-2-carboxylic acid,C5 H5 N O2,111.03207,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Pyrrole-2-carboxylic acid,5,5,1,2,0,0,0,0,1,0.4,0.3999999999999999,48.9,4,2,0.5,0.6666666666666666,1,Lignin,1800995.660184111,1604087.089676943,0.8906668267667904,-0.1670422335802608,0.8065638275373912,0.8647173323441624,Downregulated
Feature0172,"2,4-Dinitrophenol",C6 H4 N2 O5,184.01199,NA,NA,"2,4-Dinitrophenol",6,4,2,5,0,0,0,0,0.6666666666666666,0.8333333333333334,2,3.299999999999997,6,1,1,1,-1,Condensed HC,416524.2256749483,479075.19717603835,1.1501736697300873,0.20185171642303662,0.6903698683750836,0.7896538293788581,Upregulated
Feature0171,NA,C10 H N2 O4 P,243.96742,NA,NA,Feature0171,10,1,2,4,0,1,0,0,0.1,0.4,0.7999999999999998,37.5,12,8,1.6666666666666667,1.4,5,Other,49897.64216321707,97814.84530761467,1.960309967907073,0.9710817940370696,0.08047569822498976,0.2798606815761545,Upregulated
Feature0170,NA,C9 H2 N3 O3 P,230.98339000000001,NA,NA,Feature0170,9,2,3,3,0,1,0,0,0.2222222222222222,0.3333333333333333,0.8888888888888888,34.96666666666667,11,8,2,1.5714285714285714,4,Condensed HC,1733804.878857898,662745.4706382917,0.38224916697365574,-1.3874147373281898,0.2580326753979855,0.40480355498216075,Downregulated
Feature0169,"(2R)-2,3-Dihydroxypropanoic acid",C3 H6 O4,106.02664,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,"(2R)-2,3-Dihydroxypropanoic acid",3,6,0,4,0,0,0,0,2,1.3333333333333333,0.6666666666666665,41.3,1,-3,3,-1,-3,Carbohydrate,472207.5105354428,216027.6138285653,0.4574844935939467,-1.1282052507130709,0.5658823646584031,0.6887251555628964,Downregulated
Feature0168,2-Aminooctanedioic acid,C8 H15 N O4,189.10017,NA,NA,2-Aminooctanedioic acid-peak1,8,15,1,4,0,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,682765.9733044433,1272532.7080229856,1.8637904608283211,0.8982396721614403,0.16090659656202827,0.32323524831809103,Upregulated
Feature0167,beta-D-Ethyl glucuronide,C8 H14 O7,222.07389,NA,NA,beta-D-Ethyl glucuronide-peak4,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,194586.9824339509,261062.47748925665,1.341623546569307,0.4239799146921944,0.3823566349801651,0.5264704825977581,Upregulated
Feature0166,2-Keto-4-methylthiobutyric acid,C5 H8 O3 S,148.01946,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Other,Other,2-Keto-4-methylthiobutyric acid,5,8,0,3,1,0,0,0,1.6,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,200026.067420955,312556.003971757,1.56257635818027,0.6439266914555816,0.19341950252457427,0.3516526142057079,Upregulated
Feature0165,2-Hydroxycinnamic acid,C9 H8 O3,164.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of chorismate metabolism;Other,2-Hydroxycinnamic acid,9,8,0,3,0,0,0,0,0.8888888888888888,0.3333333333333333,-0.22222222222222232,66.63333333333333,6,3,0.5,0.6,3,Lignin,82204.84046155156,132903.42039614968,1.6167347281491362,0.6930829825969744,0.0732187229466752,0.2798606815761545,Upregulated
Feature0164,N-Acetylglucosaminitol,C8 H17 N O6,223.10558,NA,NA,N-Acetylglucosaminitol-peak2,8,17,1,6,0,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,4343263.061092733,1626486.9077137634,0.37448500927423706,-1.4170201264799174,0.0785772775683653,0.2798606815761545,Downregulated
Feature0163,MFCD00025555,C9 H18 N2 O3,202.13173,NA,NA,MFCD00025555,9,18,2,3,0,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,504148.38779136335,3452287.0923935464,6.847759858000855,2.7756321091943743,0.0033490449447082806,0.16328683557815518,Upregulated
Feature0162,NA,C5 H13 O6 P,200.045,NA,NA,Feature0162,5,13,0,6,0,1,0,0,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,7189839.482665255,265808.061909224,0.03696995775080777,-4.757502794957573,0.20891390440538618,0.3626830218611273,Downregulated
Feature0161,NA,C8 H16 O7,224.08956,NA,NA,Feature0161,8,16,0,7,0,0,0,0,2,0.875,-0.25,67.425,1,-6,-6,-0.5555555555555556,-6,Carbohydrate,1754994.3730913966,1523762.07107449,0.8682432801140015,-0.20382875516968385,0.5093918268744315,0.62666188773761,Downregulated
Feature0160,ascopyrone P,C6 H8 O4,144.04231,Microbial metabolism in diverse environments;Other,Other,ascopyrone P,6,8,0,4,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,1730430.9575132732,3121447.53713334,1.8038555792015163,0.8510838377561284,0.12351137243695519,0.292633686227917,Upregulated
Feature0159,NA,C8 H11 N O5,201.06374,NA,NA,Feature0159,8,11,1,5,0,0,0,0,1.375,0.625,0.25,53.175,4,-1,-1,0.1111111111111111,-2,Lignin,16925183.416896533,26787399.5495129,1.5826947862066207,0.6623830666683891,0.10438435584128616,0.28085732573866523,Upregulated
Feature0158,NA,C10 H24 N6 O5 P2,370.12836,NA,NA,Feature0158,10,24,6,5,0,2,0,0,2.4,0.5,-0.5999999999999996,77.39999999999999,3,-2,3.3333333333333335,15,-10,Other,817978.8412003093,1615388.0418543534,1.9748530897008518,0.98174533448303,0.12406983772821044,0.292633686227917,Upregulated
Feature0157,3-Hydroxy-3-methylglutaric acid,C6 H10 O5,162.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Fructose and mannose metabolism;Other,Superpathway of butirocin biosynthesis;Other,3-Hydroxy-3-methylglutaric acid,6,10,0,5,0,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,1418712.8643620657,1814131.1226597966,1.2787161998954126,0.35469610594304607,0.20086716041113592,0.35779552306976925,Upregulated
Feature0156,.alpha.-Glucoheptitol,C7 H16 O7,212.08955,NA,NA,.alpha.-Glucoheptitol-peak2,7,16,0,7,0,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,13879442.9274072,7307798.481970253,0.5265195815272835,-0.9254409080865518,0.0378286922912938,0.24912498754207058,Downregulated
Feature0155,NA,C18 H32 O17,520.16402,NA,NA,Feature0155,18,32,0,17,0,0,0,0,1.7777777777777777,0.9444444444444444,0.11111111111111116,57.133333333333326,3,-14,-14,-0.5789473684210527,-14,Carbohydrate,447391.893616447,721304.241736188,1.612242537310183,0.6890687916662505,0.3977516418580479,0.5376721799029738,Upregulated
Feature0154,NA,C12 H23 N O14,405.11204,NA,NA,Feature0154,12,23,1,14,0,0,0,0,1.9166666666666667,1.1666666666666667,0.6666666666666665,41.3,2,-12,4.333333333333333,-1.5,-13,Carbohydrate,687134.7500224647,447511.2079869117,0.6512713961450518,-0.6186692300216652,0.45773732246994675,0.5929778950178856,Downregulated
Feature0153,beta-D-Ethyl glucuronide,C8 H14 O7,222.07391,NA,NA,beta-D-Ethyl glucuronide-peak3,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,7717256.181560907,1741559.5487485668,0.22567082234612507,-2.147708194646013,0.18904621718460154,0.34723386100602177,Downregulated
Feature0152,4-Acetamidobutanoic acid,C6 H11 N O3,145.07394,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid,6,11,1,3,0,0,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,829615.2111037264,406767.3279149557,0.49030842548533954,-1.028238541704563,0.4660727925735693,0.6014977172081536,Downregulated
Feature0151,3-Phenyllactic acid,C9 H10 O3,166.06292,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,3-Phenyllactic acid,9,10,0,3,0,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,10455148.631816324,946494.9504821283,0.09052907651660023,-3.465474952175818,0.122184760097948,0.2922180975769106,Downregulated
Feature0150,Mevalonic acid,C6 H12 O4,148.07362,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Biosynthesis of terpenoids and steroids;Other,Superpathway of branched chain amino acid biosynthesis;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of L-threonine metabolism;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of L-isoleucine biosynthesis I;Other,Mevalonic acid-peak1,6,12,0,4,0,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,3104069.9044420435,831452.9083278624,0.2678589509656407,-1.9004545878984116,0.006324041675838902,0.17570143334755012,Downregulated
Feature0149,N-Acetylvaline,C7 H13 N O3,159.08948,Metabolic pathways;Other,Superpathway of L-lysine degradation,N-Acetylvaline,7,13,1,3,0,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,1047241.656578456,460304.106191083,0.4395395306322963,-1.1859351727893708,0.040413256410253895,0.24912498754207058,Downregulated
Feature0148,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one",C8 H10 O5,186.05291,NA,NA,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one-peak1",8,10,0,5,0,0,0,0,1.25,0.625,0,60.3,4,-1,-0.3333333333333333,0.2727272727272727,-1,Lignin,666113.787021235,847595.2152464283,1.272448088841926,0.34760680089982604,0.49598073293287837,0.6228456295548732,Upregulated
Feature0147,Acrylic acid,C3 H4 O2,72.02116,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid-peak2,3,4,0,2,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,421779.50367161236,789789.3922573926,1.8725172403643022,0.9049790017139756,0.14528511607461939,0.310546935609499,Upregulated
Feature0146,"5,7-Dihydroxy-2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl hydrogen sulfate",C11 H14 O7 S,290.04605,NA,NA,"5,7-Dihydroxy-2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl hydrogen sulfate",11,14,0,7,1,0,0,0,1.2727272727272727,0.6363636363636364,0.18181818181818168,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Lignin,30418.353073792397,53919.77159512333,1.772606540016103,0.8258723412214583,0.09674764932318028,0.28085732573866523,Upregulated
Feature0145,DL-4-Hydroxyphenyllactic acid,C9 H10 O4,182.05791,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,DL-4-Hydroxyphenyllactic acid,9,10,0,4,0,0,0,0,1.1111111111111112,0.4444444444444444,-0.22222222222222232,66.63333333333333,5,1,0.2,0.42857142857142855,1,Lignin,10908312.74589413,840988.795595422,0.07709613898922808,-3.6971975786690687,0.08014267837812064,0.2798606815761545,Downregulated
Feature0144,NA,C5 H12 N2 S2,164.04417,NA,NA,Feature0144,5,12,2,0,2,0,0,0,2.4,0,-0.4000000000000003,71.7,1,1,-3,-3,-3,Lipid,48184.962709746665,106654.0959931812,2.213431120319361,1.1462844789610362,0.06298174675020206,0.27718515590669207,Upregulated
Feature0143,NA,C33 H38 O10,594.2465,NA,NA,Feature0143,33,38,0,10,0,0,0,0,1.1515151515151516,0.30303030303030304,-0.5454545454545459,75.84545454545456,15,5,0.21739130434782608,0.35714285714285715,5,Lignin,28327.6886569077,57246.566162319,2.0208696465025375,1.0149762656021055,0.016209933704849844,0.20510808338839256,Upregulated
Feature0142,"2-(3,4-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",C21 H24 O8,404.14731,NA,NA,"2-(3,4-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",21,24,0,8,0,0,0,0,1.1428571428571428,0.380952380952381,-0.3809523809523814,71.15714285714287,10,2,0.15384615384615383,0.35294117647058826,2,Lignin,120368.32155544733,192331.41043709966,1.5978573760248267,0.6761386397523919,0.04892861538570624,0.24912498754207058,Upregulated
Feature0141,.,C3 H6 O2,74.0368,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Fructose and mannose metabolism;Other,Superpathway of L-threonine metabolism;Superpathway of coenzyme A biosynthesis II (plants);Other,.,3,6,0,2,0,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-1,-1,0,-1,Amino Sugar,907316.3507901009,136254.4900652497,0.15017307904414798,-2.7353018853010314,0.20522772894987873,0.360586104548962,Downregulated
Feature0140,D-(-)-Glutamine,C5 H10 N2 O3,146.06919,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;Central carbon metabolism in cancer;Other,Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Superpathway of purine nucleotide salvage;Superpathway of chorismate metabolism;Superpathway of butirocin biosynthesis;Other,D-(-)-Glutamine,5,10,2,3,0,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,7421470.70624316,15137753.0825092,2.0397241573391747,1.028374062124944,0.006019527902074152,0.17570143334755012,Upregulated
Feature0139,"3,12-Dihydroxy-13-methoxypodocarpa-8,11,13-trien-7-one",C18 H24 O4,304.16748,NA,NA,"3,12-Dihydroxy-13-methoxypodocarpa-8,11,13-trien-7-one",18,24,0,4,0,0,0,0,1.3333333333333333,0.2222222222222222,-0.8888888888888893,85.63333333333334,7,3,0.21428571428571427,0.3125,3,Lignin,685961.5818137624,26273694.445183754,38.301991163576595,5.259347488790802,0.16060078187539098,0.32323524831809103,Upregulated
Feature0138,cis-Aconitic acid,C6 H6 O6,174.0164,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Other,Superpathway of betalain biosynthesis;Other,cis-Aconitic acid,6,6,0,6,0,0,0,0,1,1,1,31.799999999999997,4,-2,-Inf,0.3333333333333333,-2,Tannin,4058037.501703771,4021551.1026042057,0.9910088561073558,-0.013030144836774895,0.990323814896917,0.9915961142612164,Downregulated
Feature0137,glutaral,C5 H8 O2,100.05245,NA,NA,glutaral,5,8,0,2,0,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,132005.77796849282,125540.17216123796,0.951020281787983,-0.07245198605921847,0.9112838311530185,0.9415681880795539,Downregulated
Feature0136,beta-D-Ethyl glucuronide,C8 H14 O7,222.07396,NA,NA,beta-D-Ethyl glucuronide-peak2,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,1154599.5529366897,624523.5551368453,0.5409005689880861,-0.8865646797848249,0.09406105585837907,0.28085732573866523,Downregulated
Feature0135,MS 3 (enzyme inhibitor),C21 H24 O7,388.15231,NA,NA,MS 3 (enzyme inhibitor),21,24,0,7,0,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,35941.45814856143,113482.81204240394,3.1574348367651335,1.658752959936539,0.014181020870464783,0.20510808338839256,Upregulated
Feature0134,UDP-N-acetylglucosamine,C17 H27 N3 O17 P2,607.08161,Metabolic pathways;Other,Chitin biosynthesis;Superpathway of CMP-sialic acids biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Superpathway of butirocin biosynthesis;Other,UDP-N-acetylglucosamine,17,27,3,17,0,2,0,0,1.588235294117647,1,0.3529411764705883,50.24117647058823,7,-10,3,-1.8571428571428572,-15,Carbohydrate,12118111.759463767,15627150.7467542,1.2895697825653416,0.36688984388090345,0.05843700249286598,0.26647273136746885,Upregulated
Feature0133,NA,C4 H11 O6 P,186.02928,NA,NA,Feature0133,4,11,0,6,0,1,0,0,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,11551191.086402979,10639599.800469853,0.9210824858567036,-0.11859773487069679,0.8296086564338383,0.8756980262357182,Downregulated
Feature0132,(Â±)9-HpODE,C18 H32 O4,312.2302,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,(Â±)9-HpODE,18,32,0,4,0,0,0,0,1.7777777777777777,0.2222222222222222,-1.333333333333333,98.29999999999998,3,-1,-0.07142857142857142,0.0625,-1,Lipid,3619486.4687948264,15393192.4908883,4.2528664283178665,2.088435544305425,0.02175645934375048,0.22428260510688935,Upregulated
Feature0131,"3,5-Dihydroxybenzoic acid",C7 H6 O4,154.02666,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of phenylpropanoids;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Other,"3,5-Dihydroxybenzoic acid",7,6,0,4,0,0,0,0,0.8571428571428571,0.5714285714285714,0.2857142857142856,52.15714285714286,5,1,0.3333333333333333,0.6,1,Lignin,140277.31239923366,192160.11246052966,1.3698588116204844,0.45402720539628916,0.3358438045509064,0.4825990804891176,Upregulated
Feature0130,Adenosine,C10 H13 N5 O4,267.09685,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine-peak2,10,13,5,4,0,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,132616214.358838,185060212.76317567,1.3954569104380607,0.48073757688904284,0.03071191522246925,0.2313912399951807,Upregulated
Feature0129,1-Deoxy-L-mannitol,C6 H14 O5,166.08408,NA,NA,1-Deoxy-L-mannitol-peak2,6,14,0,5,0,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,164004916.91618267,175633987.40426633,1.070906840518854,0.09883298376031423,0.6984459652548684,0.7923405566790547,Upregulated
Feature0128,Methyl acetoacetate,C5 H8 O3,116.04739,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of L-lysine degradation;Other,Methyl acetoacetate,5,8,0,3,0,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,50399112.92680383,2389087.9789549634,0.04740337359557715,-4.398866453511621,0.21304415826727208,0.36430551063703526,Downregulated
Feature0127,4-Hydroxy-2-methylbenzoic acid,C8 H8 O3,152.04741,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of phenylpropanoids;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,4-Hydroxy-2-methylbenzoic acid,8,8,0,3,0,0,0,0,1,0.375,-0.25,67.425,5,2,0.4,0.5384615384615384,2,Lignin,46450109.12648568,1705918.011144665,0.03672581277472084,-4.767061770522541,0.18730435246925822,0.3462599380783044,Downregulated
Feature0126,4-Nitrophenol,C6 H5 N O3,139.02701,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,4-Nitrophenol,6,5,1,3,0,0,0,0,0.8333333333333334,0.5,0.6666666666666665,41.3,5,2,0.5,0.7142857142857143,1,Lignin,1549221.49997481,2477099.9034083267,1.5989320464817998,0.6771086265687611,0.14339331247978843,0.30872903951326996,Upregulated
Feature0125,D-(â)-Erythrose,C4 H8 O4,120.04229,NA,NA,D-(â)-Erythrose-peak2,4,8,0,4,0,0,0,0,2,1,0,60.3,1,-3,-Inf,-0.5,-3,Carbohydrate,1746916.3648911468,3535519.7752572233,2.023863217674721,1.0171117891178765,0.04535087197901203,0.24912498754207058,Upregulated
Feature0124,Acrylic acid,C3 H4 O2,72.02115,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid-peak1,3,4,0,2,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,5315265.168808233,13602144.2823313,2.559071626784166,1.3556205280573708,0.00979018317454554,0.20510808338839256,Upregulated
Feature0123,"1,5-Anhydro-D-fructose",C6 H10 O5,162.0528,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Fructose and mannose metabolism;Other,Superpathway of butirocin biosynthesis;Other,"1,5-Anhydro-D-fructose",6,10,0,5,0,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,4749707.367609844,9498284.79119741,1.9997621023918268,0.9998283829432004,0.018752264818132327,0.20687982476778247,Upregulated
Feature0122,NA,C7 H8 O6 S,220.00407,NA,NA,Feature0122,7,8,0,6,1,0,0,0,1.1428571428571428,0.8571428571428571,0.8571428571428572,35.87142857142857,4,-2,-Inf,0,-3,Tannin,29141.8383321351,256938.8972870736,8.816839018825508,3.140261518680309,0.37247760317349704,0.519948327695249,Upregulated
Feature0121,Xylitol,C5 H12 O5,152.0685,Metabolic pathways;ABC transporters;Other,Other,Xylitol,5,12,0,5,0,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,364365393.9926223,317889540.10868466,0.8724471240952189,-0.19686039751029666,0.6071358142837058,0.7172759172773918,Downregulated
Feature0120,Gluconic acid,C6 H12 O7,196.05834,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Galactose metabolism;Carbon metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,Gluconic acid,6,12,0,7,0,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,622700.0861590856,947277.2878048293,1.5212416199390435,0.6052493155893347,0.16256275646406917,0.32323524831809103,Upregulated
Feature0119,NA,C27 H37 N O5,455.26725,NA,NA,Feature0119,27,37,1,5,0,0,0,0,1.3703703703703705,0.18518518518518515,-0.8888888888888893,85.63333333333334,10,5,0.1904761904761905,0.2765957446808511,4,Lignin,1876579.6503804857,371372.892159783,0.19789881665000755,-2.3371651091733368,0.20151410600437558,0.35779552306976925,Downregulated
Feature0118,Glyceraldehyde,C3 H6 O3,90.03168,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Galactose metabolism;Carbon metabolism;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Other,Superpathway of anaerobic sucrose degradation;Superpathway of microbial D-galacturonate and D-glucuronate degradation;Homolactic fermentation;Superpathway of coenzyme A biosynthesis II (plants);Other,Glyceraldehyde,3,6,0,3,0,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,57527753.062756665,115051860.09474279,1.9999366213596668,0.9999542812505446,0.07343398893235534,0.2798606815761545,Upregulated
Feature0117,D-(+)-Glucose,C6 H12 O6,180.06335,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Galactose metabolism;Carbon metabolism;Biosynthesis of phenylpropanoids;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of scopolin and esculin biosynthesis;Homolactic fermentation;Superpathway of CMP-sialic acids biosynthesis;Superpathway of betalain biosynthesis;Other,D-(+)-Glucose,6,12,0,6,0,0,0,0,2,1,0,60.3,1,-5,-Inf,-0.6666666666666666,-5,Carbohydrate,103951329.44207656,195745987.65309432,1.8830542014584555,0.9130745267975583,0.20089031650167447,0.35779552306976925,Upregulated
Feature0116,L-Iditol,C6 H14 O6,182.07904,Metabolic pathways;ABC transporters;Galactose metabolism;Fructose and mannose metabolism;Phosphotransferase system (PTS);Other,Other,L-Iditol-peak3,6,14,0,6,0,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,1354128550.84196,1992431575.4715967,1.47137550141215,0.557165475615746,0.035346316602630774,0.24670286281836173,Upregulated
Feature0115,D-(+)-Maltose,C12 H22 O11,342.11635,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,D-(+)-Maltose,12,22,0,11,0,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,5351287.83875371,7417984.760282867,1.386205523568039,0.471141172230305,0.4857501022744543,0.6174771457433144,Upregulated
Feature0114,NA,C29 H30 O10,538.1839,NA,NA,Feature0114,29,30,0,10,0,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,61231.021577326464,304204.7871943453,4.968148160163815,2.312708198265789,0.1475817339795285,0.3115726308769368,Upregulated
Feature0113,NA,C29 H30 O10,538.18389,NA,NA,Feature0113,29,30,0,10,0,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,81652.65910271344,237979.897751385,2.9145394695844824,1.5432679391939865,0.24003976377104794,0.3854159587309784,Upregulated
Feature0112,MFCD12974029,C4 H11 N O4 S,169.04083,NA,NA,MFCD12974029,4,11,1,4,1,0,0,0,2.75,1,0.5,46.05,0,-4,3,-Inf,-6,Other,79072757.2049696,157571629.76898602,1.9927423216131748,0.9947551696024239,0.0145398306437503,0.20510808338839256,Upregulated
Feature0111,Perillic acid,C10 H14 O2,166.09931,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Perillic acid,10,14,0,2,0,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Lignin,42492.5161230668,354559.02108351013,8.34403451319843,3.060745125249486,0.3833074566281923,0.5264704825977581,Upregulated
Feature0110,NA,C12 H23 N O14,405.11202,NA,NA,Feature0110,12,23,1,14,0,0,0,0,1.9166666666666667,1.1666666666666667,0.6666666666666665,41.3,2,-12,4.333333333333333,-1.5,-13,Carbohydrate,388327.21924134565,1464957.1654245353,3.7724812808294628,1.9155137420716388,0.4082540819107326,0.5496964409979156,Upregulated
Feature0109,MFCD00155202,C10 H12 O4,196.07357,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,MFCD00155202-peak1,10,12,0,4,0,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Lignin,945122.091432741,968333.800178782,1.0245594817393948,0.035003743762917185,0.9726301087656617,0.9821555262770645,Upregulated
Feature0108,3-Allyl-2-hydroxybenzoic acid,C10 H10 O3,178.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,NA,3-Allyl-2-hydroxybenzoic acid-peak2,10,10,0,3,0,0,0,0,1,0.3,-0.4000000000000003,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Lignin,436201.1028901327,293940.0281570393,0.6738635602007519,-0.5694715820380882,0.5008261641157606,0.6228456295548732,Downregulated
Feature0107,beta-D-Ethyl glucuronide,C8 H14 O7,222.0739,NA,NA,beta-D-Ethyl glucuronide-peak1,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,393964.14872998704,946197.9228531463,2.4017361120380682,1.2640776453115365,0.1386145328066701,0.30872903951326996,Upregulated
Feature0106,DL-Lactic Acid,C3 H6 O3,90.03169,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Galactose metabolism;Carbon metabolism;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Other,Superpathway of anaerobic sucrose degradation;Superpathway of microbial D-galacturonate and D-glucuronate degradation;Homolactic fermentation;Superpathway of coenzyme A biosynthesis II (plants);Other,DL-Lactic Acid,3,6,0,3,0,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,4078755.38832081,6678406.756280507,1.6373638819831144,0.711374976909417,0.34357222063130116,0.48959041439960416,Upregulated
Feature0105,Gentisyl Alcohol,C7 H8 O3,140.04739,Microbial metabolism in diverse environments;Other,NA,Gentisyl Alcohol,7,8,0,3,0,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,9014728.635433717,10349858.092513276,1.1481053408342916,0.19925501808245047,0.5986340694316572,0.7172759172773918,Upregulated
Feature0104,NA,C10 H5 N2 O6 P,279.98865,NA,NA,Feature0104,10,5,2,6,0,1,0,0,0.5,0.6,0.7999999999999998,37.5,10,4,1,1,1,Condensed HC,26954514.502974533,92143869.43341604,3.4184948656095293,1.773361258477728,0.10593741234002287,0.28085732573866523,Upregulated
Feature0103,NA,C28 H28 O10,524.16829,NA,NA,Feature0103,28,28,0,10,0,0,0,0,1,0.35714285714285715,-0.2857142857142856,68.44285714285714,15,5,0.2777777777777778,0.43478260869565216,5,Lignin,75184.95865931224,136091.2772627699,1.8100864812527757,0.8560586271946473,0.08383157923756852,0.28085732573866523,Upregulated
Feature0102,NA,C10 H3 N2 O5 P,261.97802,NA,NA,Feature0102,10,3,2,5,0,1,0,0,0.3,0.5,0.7999999999999998,37.5,11,6,1.5,1.2222222222222223,3,Condensed HC,35063863.42357633,17210292.891513865,0.4908270570076988,-1.026713314641843,0.0018424136380999722,0.1575263660575476,Downregulated
Feature0101,Phenylacetaldehyde,C8 H8 O,120.05755,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,Phenylacetaldehyde,8,8,0,1,0,0,0,0,1,0.125,-0.75,81.675,5,4,0.5714285714285714,0.6,4,Unsaturated HC,48389.685097277565,126949.52583382551,2.623483198508514,1.3914835506035292,0.1565540615275147,0.3206077188168265,Upregulated
Feature0100,Î´-Gluconic acid Î´-lactone,C6 H10 O6,178.04765,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Galactose metabolism;Carbon metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,Î´-Gluconic acid Î´-lactone,6,10,0,6,0,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,449314.520600077,688111.2230175936,1.531468918695515,0.6149160876036246,0.10700415019552806,0.2809171845669831,Upregulated
Feature0099,NA,C18 H34 O18,538.17464,NA,NA,Feature0099,18,34,0,18,0,0,0,0,1.8888888888888888,1,0.11111111111111116,57.133333333333326,2,-16,-Inf,-0.7777777777777778,-16,Carbohydrate,187558.493451539,277885.36280998,1.4815930630290517,0.5671492488801884,0.16045316684659766,0.32323524831809103,Upregulated
Feature0098,"8-(3-Furyl)-10-methyl-6,15-dioxo-7,14-dioxatetracyclo[11.2.1.0~2,11~.0~5,10~]hexadec-3-yl acetate",C21 H24 O7,388.15237,NA,NA,"8-(3-Furyl)-10-methyl-6,15-dioxo-7,14-dioxatetracyclo[11.2.1.0~2,11~.0~5,10~]hexadec-3-yl acetate",21,24,0,7,0,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,40048.1382624568,67047.9545688819,1.6741840564343071,0.7434581436040061,0.09687124818465363,0.28085732573866523,Upregulated
Feature0097,NA,C32 H36 O11,596.22573,NA,NA,Feature0097,32,36,0,11,0,0,0,0,1.125,0.34375,-0.4375,72.76875,15,4,0.1904761904761905,0.3584905660377358,4,Lignin,41360.85302263937,127101.4061844241,3.0729880284348483,1.619642146575744,0.272770880879158,0.42253987173455193,Upregulated
Feature0096,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09473,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak2",14,16,0,6,0,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,87289.6433887434,106200.95508934783,1.2166501198359023,0.2829143422909351,0.5087464349384524,0.62666188773761,Upregulated
Feature0095,1-Deoxy-L-mannitol,C6 H14 O5,166.08409,NA,NA,1-Deoxy-L-mannitol-peak1,6,14,0,5,0,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,44609103.47425053,31644882.55893457,0.7093817201953133,-0.4953659404295337,0.040961496853313524,0.24912498754207058,Downregulated
Feature0094,NA,C9 H17 N O6,235.10561,NA,NA,Feature0094,9,17,1,6,0,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,24135586.959828593,23675929.248856034,0.980955188214912,-0.027740861823842347,0.9745125395507039,0.9821555262770645,Downregulated
Feature0093,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid,C9 H8 O6 S,244.00412,NA,NA,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid-peak1,9,8,0,6,1,0,0,0,0.8888888888888888,0.6666666666666666,0.6666666666666665,41.3,6,0,-0.5,0.4,-1,Tannin,48021.882998412904,149821.41299425566,3.11985710762752,1.6414799538189275,0.014054895760380793,0.20510808338839256,Upregulated
Feature0092,L-Saccharopine,C11 H20 N2 O6,276.13221,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Superpathway of L-lysine degradation,L-Saccharopine,11,20,2,6,0,0,0,0,1.818181818181818,0.5454545454545454,-0.18181818181818168,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,36438925.850509234,11813109.862849467,0.3241892999621551,-1.6250916201524652,0.053764644381667004,0.25538206081291825,Downregulated
Feature0091,L-Iditol,C6 H14 O6,182.07903,Metabolic pathways;ABC transporters;Galactose metabolism;Fructose and mannose metabolism;Phosphotransferase system (PTS);Other,Other,L-Iditol-peak2,6,14,0,6,0,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,44191410.26002017,11294851.4070771,0.25558929530917274,-1.968100680855091,0.04250525420697101,0.24912498754207058,Downregulated
Feature0090,EPERVUDINE,C12 H18 N2 O5,270.12157,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,EPERVUDINE,12,18,2,5,0,0,0,0,1.5,0.4166666666666667,-0.16666666666666696,65.05000000000001,5,0,-0.4,0.06666666666666667,-2,Protein,82307.69176840094,158406.85849030034,1.9245693213707022,0.9445356367484332,0.0958923258468726,0.28085732573866523,Upregulated
Feature0089,"2,4,6-Trihydroxyacetophenone",C8 H8 O4,168.04223,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"2,4,6-Trihydroxyacetophenone-peak1",8,8,0,4,0,0,0,0,1,0.5,0,60.3,5,1,0.25,0.5,1,Lignin,147522.4390335532,343523.7349640287,2.3286202235708426,1.2194753685108215,0.05075612288953863,0.24912498754207058,Upregulated
Feature0088,N-Acetyl-b-D-galactosamine,C8 H15 N O6,221.08996,Metabolic pathways;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of CMP-sialic acids biosynthesis;Other,N-Acetyl-b-D-galactosamine,8,15,1,6,0,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,17716113.753050264,30870373.402443867,1.7425025506583673,0.8011607678982805,0.3252347667547646,0.47534312064157896,Upregulated
Feature0087,NA,C15 H31 O17 P,514.12992,NA,NA,Feature0087,15,31,0,17,0,1,0,0,2.066666666666667,1.1333333333333333,-0.13333333333333375,64.10000000000001,1,-16,5.666666666666667,-1.5454545454545454,-17,Carbohydrate,2569491.432241713,3060391.1896957667,1.1910493848293455,0.252233233329062,0.48387133060869386,0.6174771457433144,Upregulated
Feature0086,3-Allyl-2-hydroxybenzoic acid,C10 H10 O3,178.06298,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,NA,3-Allyl-2-hydroxybenzoic acid-peak1,10,10,0,3,0,0,0,0,1,0.3,-0.4000000000000003,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Lignin,41228.0548181931,78154.74468028924,1.895668981351047,0.9227070651559263,0.20665168564794312,0.360586104548962,Upregulated
Feature0085,NA,C6 H13 N O9,243.05903,NA,NA,Feature0085,6,13,1,9,0,0,0,0,2.1666666666666665,1.5,1.3333333333333337,22.29999999999999,1,-8,2.25,-9,-9,Carbohydrate,4680072.452554306,9713410.411742423,2.075482914039291,1.053447055317938,0.026584695874617554,0.22954141724043495,Upregulated
Feature0084,6-Deoxy-3-O-methyl-beta-D-galactopyranose,C7 H14 O5,178.08412,NA,NA,6-Deoxy-3-O-methyl-beta-D-galactopyranose-peak1,7,14,0,5,0,0,0,0,2,0.7142857142857143,-0.5714285714285712,76.58571428571427,1,-4,-2,-0.3333333333333333,-4,Carbohydrate,1648784.2555041332,3903498.1665976,2.367500874396732,1.24336495852897,0.21459895123341705,0.3651385140389484,Upregulated
Feature0083,D-Raffinose,C18 H32 O16,504.16918,Metabolic pathways;ABC transporters;Galactose metabolism;Other,NA,D-Raffinose,18,32,0,16,0,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,2181766.1657380713,423204.03013719036,0.19397313826893284,-2.366071215513037,0.44619152904034753,0.5836426779414513,Downregulated
Feature0082,"7a-Hydroxy-3,6-dimethyl-5,6,7,7a-tetrahydro-1-benzofuran-2(4H)-one",C10 H14 O3,182.09428,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"7a-Hydroxy-3,6-dimethyl-5,6,7,7a-tetrahydro-1-benzofuran-2(4H)-one",10,14,0,3,0,0,0,0,1.4,0.3,-0.7999999999999998,83.1,4,1,0.14285714285714285,0.29411764705882354,1,Lignin,936487.1196518124,2286934.51049508,2.4420351999559444,1.2880839957536054,0.04116567230908115,0.24912498754207058,Upregulated
Feature0081,9(S)-HpOTrE,C18 H30 O4,310.2145,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,9(S)-HpOTrE,18,30,0,4,0,0,0,0,1.6666666666666667,0.2222222222222222,-1.2222222222222223,95.13333333333333,4,0,0,0.125,0,Lipid,1504917.2720367927,20265607.044699535,13.466259854451371,3.7512773043588235,0.029997832912194978,0.2313912399951807,Upregulated
Feature0080,"4-(1,3-Benzodioxol-5-ylmethyl)-3-(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",C22 H26 O7,402.16802,NA,NA,"4-(1,3-Benzodioxol-5-ylmethyl)-3-(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",22,26,0,7,0,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,48649.831453995,153046.29913952778,3.1458752181752936,1.653461447075927,0.277352273378111,0.4253564013242779,Upregulated
Feature0079,Glycerol 3-phosphate,C3 H9 O6 P,172.01364,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Other,Glycerol 3-phosphate,3,9,0,6,0,1,0,0,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,25171584.616925232,43307767.57101557,1.720502234169861,0.782829765497554,0.2300563223457182,0.3784879540454062,Upregulated
Feature0078,Glucose 1-phosphate,C6 H13 O9 P,260.02973,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Galactose metabolism;Carbon metabolism;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Homolactic fermentation;Superpathway of CMP-sialic acids biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of butirocin biosynthesis;Other,Glucose 1-phosphate,6,13,0,9,0,1,0,0,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,1328290.61417648,2091575.5407901003,1.5746369946962588,0.6550192785728356,0.37734896359412057,0.5246070957284115,Upregulated
Feature0077,NA,C6 H7 N3 O6 P2,278.98094,NA,NA,Feature0077,6,7,3,6,0,2,0,0,1.1666666666666667,1,0.6666666666666665,41.3,6,0,1,1,-5,Tannin,274457.89539826603,497791.80413495697,1.8137273967382537,0.8589576350684088,0.027124365343106364,0.22954141724043495,Upregulated
Feature0076,Azelaic acid,C9 H16 O4,188.10484,NA,NA,Azelaic acid,9,16,0,4,0,0,0,0,1.7777777777777777,0.4444444444444444,-0.8888888888888893,85.63333333333334,2,-2,-0.4,0,-2,Protein,3469113.38462077,5279589.549589343,1.5218844022206808,0.6058587802103381,0.016066478870436413,0.20510808338839256,Upregulated
Feature0075,L-Glutathione oxidized,C20 H32 N6 O12 S2,612.15171,Metabolic pathways;Biosynthesis of cofactors;Other,Other,L-Glutathione oxidized,20,32,6,12,2,0,0,0,1.6,0.6,0.7000000000000002,40.349999999999994,8,-4,-Inf,-1,-12,Amino Sugar,79305.62344759813,328631.27942869137,4.143858469832688,2.0509747297722076,0.1415470365375872,0.30872903951326996,Upregulated
Feature0074,NA,C18 H22 O7 S,382.10881,NA,NA,Feature0074,18,22,0,7,1,0,0,0,1.2222222222222223,0.3888888888888889,-0.33333333333333304,69.79999999999998,8,1,0,0.25925925925925924,0,Lignin,50359.150236348265,12143421.244922789,241.1363414182057,7.91370528423578,0.07267647442039091,0.2798606815761545,Upregulated
Feature0073,N-Phenylacetylglutamic acid,C13 H15 N O5,265.0951,NA,NA,N-Phenylacetylglutamic acid,13,15,1,5,0,0,0,0,1.1538461538461535,0.38461538461538464,-0.1538461538461542,64.6846153846154,7,2,0.14285714285714285,0.3684210526315789,1,Lignin,1234769.84233339,381730.7920538547,0.3091513729655755,-1.6936146821526026,0.004505632650971645,0.16328683557815518,Downregulated
Feature0072,Pyruvic acid,C3 H4 O3,88.01606,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Carbon metabolism;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Glucagon signaling pathway;Central carbon metabolism in cancer;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of microbial D-galacturonate and D-glucuronate degradation;Homolactic fermentation;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of L-threonine metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of L-lysine degradation;Other,Pyruvic acid,3,4,0,3,0,0,0,0,1.3333333333333333,1,0.6666666666666665,41.3,2,-1,-Inf,0.3333333333333333,-1,Tannin,2260856.8781762933,1594733.3353949673,0.7053667796438974,-0.5035544635116057,0.67575219689613,0.7755276890552901,Downregulated
Feature0071,Phenylpyruvic acid,C9 H8 O3,164.04728,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of chorismate metabolism;Other,Phenylpyruvic acid,9,8,0,3,0,0,0,0,0.8888888888888888,0.3333333333333333,-0.22222222222222232,66.63333333333333,6,3,0.5,0.6,3,Lignin,1391218.8248655987,362335.54280179733,0.260444680826398,-1.9409511222784586,0.20639855717647757,0.360586104548962,Downregulated
Feature0070,2-isopropylmaleic acid,C7 H10 O4,158.05784,Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,2-isopropylmaleic acid,7,10,0,4,0,0,0,0,1.4285714285714286,0.5714285714285714,-0.2857142857142856,68.44285714285714,3,-1,-0.3333333333333333,0.2,-1,Lignin,13419918.653897267,15246983.909801625,1.136145777260264,0.18414795688260713,0.8143949318300469,0.8703845833933627,Upregulated
Feature0069,L-Serine,C3 H7 N O3,105.04262,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Carbon metabolism;Biosynthesis of amino acids;Central carbon metabolism in cancer;Other,Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of chorismate metabolism;Other,L-Serine,3,7,1,3,0,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,7681765.901243486,10240939.570318783,1.333149135495138,0.4148381795298965,0.07940837590781566,0.2798606815761545,Upregulated
Feature0068,NA,C8 H21 N8 O8 P,388.12197,NA,NA,Feature0068,8,21,8,8,0,1,0,0,2.625,1,1.75,10.424999999999995,3,-5,1.5555555555555556,2,-14,Other,162657840.30593303,166000339.29132968,1.0205492645119962,0.02934582661528447,0.96871433544842,0.9821555262770645,Upregulated
Feature0067,Propylparaben,C10 H12 O3,180.07863,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,NA,Propylparaben,10,12,0,3,0,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,20163440.139977433,11321116.823787354,0.5614675246483026,-0.83272551550954,0.0561210322944765,0.2593701762798779,Downregulated
Feature0066,NA,C19 H32 O3 S,340.20729,NA,NA,Feature0066,19,32,0,3,1,0,0,0,1.6842105263157894,0.15789473684210523,-1.2631578947368425,96.3,4,1,0,0.09090909090909093,0,Lipid,1576007.23338725,2517801.0391569436,1.5975821594076909,0.67589012705466045,0.2899355574567081,0.4368192099127497,Upregulated
Feature0065,3-Hydroxyvaleric acid,C5 H10 O3,118.06304,Metabolic pathways;Other,NA,3-Hydroxyvaleric acid,5,10,0,3,0,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,6242797.071589479,248948.19117661568,0.039877668346703275,-4.648275132169738,0.1793204378246639,0.3462599380783044,Downregulated
Feature0064,D-Glucopyranuronic acid,C6 H10 O7,194.04263,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,D-Glucopyranuronic acid,6,10,0,7,0,0,0,0,1.6666666666666667,1.1666666666666667,0.6666666666666665,41.3,2,-5,5,-0.6,-5,Carbohydrate,872410.007821504,749486.4356417813,0.8590988513684348,-0.2191039516796953,0.7225901512354611,0.8129139201398937,Downregulated
Feature0063,APM,C7 H13 N O4,175.08439,NA,NA,APM,7,13,1,4,0,0,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,188207.193992719,259564.619519765,1.3791429222934302,0.4637719728776816,0.288892651112844,0.4368192099127497,Upregulated
Feature0062,D-Glucono-delta-lactone,C6 H10 O6,178.04772,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Galactose metabolism;Carbon metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,D-Glucono-delta-lactone-peak1,6,10,0,6,0,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,7156938.13773031,5966224.0219523,0.8336279994512259,-0.2625243599880161,0.768806696690422,0.8427304175260396,Downregulated
Feature0061,NA,C3 H9 N7 O11,319.03608,NA,NA,Feature0061,3,9,7,11,0,0,0,0,3,3.6666666666666665,11.333333333333332,-262.69999999999993,3,-8,1,1,-15,Other,434348.267223633,125310.85437055954,0.28850317550833166,-1.7933408964155317,0.18986178949744464,0.34723386100602177,Downregulated
Feature0060,NA,C9 H18 O10,286.09013,NA,NA,Feature0060,9,18,0,10,0,0,0,0,2,1.1111111111111112,0.22222222222222232,53.96666666666666,1,-9,9,-1,-9,Carbohydrate,110584.1752668414,213374.60213116833,1.9295220280505052,0.9482435142485997,0.07994629460362354,0.2798606815761545,Upregulated
Feature0059,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03784,NA,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Lignin,456531.83840684465,718499.082064576,1.5738203157350783,0.6542708366550655,0.3318391001424071,0.48088547563009837,Upregulated
Feature0058,NA,C11 H16 N2 O7,288.09583,NA,NA,Feature0058,11,16,2,7,0,0,0,0,1.4545454545454546,0.6363636363636364,0.36363636363636376,49.93636363636363,5,-2,-2,-0.09090909090909093,-4,Lignin,18856229.6846334,26179672.665025435,1.3883832082486864,0.4734058217608707,0.1830039794862259,0.3462599380783044,Upregulated
Feature0057,NA,C17 H32 O17,508.16405,NA,NA,Feature0057,17,32,0,17,0,0,0,0,1.8823529411764703,1,0.11764705882352944,56.94705882352941,2,-15,-Inf,-0.7647058823529411,-15,Carbohydrate,70818.98501440289,130641.7105133459,1.8447272364433986,0.8834075134554382,0.1019839982638892,0.28085732573866523,Upregulated
Feature0056,NA,C7 H16 N O7 P,257.0665,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Feature0056,7,16,1,7,0,1,0,0,2.2857142857142856,1,-0.5714285714285712,76.58571428571427,1,-6,4,-3,-8,Carbohydrate,517402.802387329,403088.698603307,0.7790616841335811,-0.36019053313383337,0.41137618160940886,0.5515742399361392,Downregulated
Feature0055,"5,7-Dihydroxy-4-methylcoumarin",C10 H8 O4,192.04227,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of phenylpropanoids;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,"5,7-Dihydroxy-4-methylcoumarin",10,8,0,4,0,0,0,0,0.8,0.4,0,60.3,7,3,0.5,0.625,3,Condensed HC,68544.88451745884,169979.68111734456,2.4798302938864767,1.3102413937791837,0.10472544502030662,0.28085732573866523,Upregulated
Feature0054,Dichloroacetic acid,C2 H2 Cl2 O2,127.94324,Microbial metabolism in diverse environments;Other,NA,Dichloroacetic acid,3,2,0,2,0,0,0,2,0.6666666666666666,0.6666666666666666,0.6666666666666665,41.3,3,1,1,1,1,Condensed HC,569268.3926682957,248128.126131776,0.4358719530672356,-1.1980237209101106,0.3459742334167907,0.4909675843507984,Downregulated
Feature0053,Uridine 5'-diphosphogalactose,C15 H24 N2 O17 P2,566.05509,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Galactose metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of anaerobic sucrose degradation;Superpathway of scopolin and esculin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Superpathway of betalain biosynthesis;Other,Uridine 5'-diphosphogalactose,15,24,2,17,0,2,0,0,1.6,1.1333333333333333,0.3999999999999999,48.9,6,-11,2.5,-2.6,-15,Carbohydrate,3610015.1760033835,3399698.6367514036,0.9417408157588912,-0.08659803639742523,0.6082164210831685,0.7172759172773918,Downregulated
Feature0052,N-Acetylglucosaminitol,C8 H17 N O6,223.10559,NA,NA,N-Acetylglucosaminitol-peak1,8,17,1,6,0,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,1213434.4539717636,1230929.2136571046,1.0144175564061808,0.020651619360613008,0.9715534295623176,0.9821555262770645,Upregulated
Feature0051,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08486,NA,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,1491774.89052579,320895.10401964467,0.2151096027005403,-2.2168561653880285,0.04561579636190728,0.24912498754207058,Downregulated
Feature0050,NA,C8 H7 N3 O6 P2,302.98095,NA,NA,Feature0050,8,7,3,6,0,2,0,0,0.875,0.75,0.5,46.05,8,2,1,NA,-3,Tannin,249562.17040844468,428015.856213121,1.715067053282198,0.7782649819646332,0.1316418991840764,0.30419952379023063,Upregulated
Feature0049,NA,C7 H12 O8,224.05313,NA,NA,Feature0049,7,12,0,8,0,0,0,0,1.7142857142857142,1.1428571428571428,0.5714285714285716,44.014285714285705,2,-6,6,-0.6666666666666666,-6,Carbohydrate,127417.3776507285,233948.10061513333,1.8360768752942214,0.876626464679768,0.0985039346984515,0.28085732573866523,Upregulated
Feature0048,Adenosine,C10 H13 N5 O4,267.09688,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine-peak1,10,13,5,4,0,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,5796641.763101587,9876767.141560683,1.7038774423548229,0.7688215681542788,0.06344460876944268,0.27718515590669207,Upregulated
Feature0047,3797,C8 H10 O4,170.05789,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,3797,8,10,0,4,0,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,296382.93235420564,427720.61769211636,1.4431351167716695,0.5292063817214578,0.06948657306267675,0.2798606815761545,Upregulated
Feature0046,Threonine,C4 H9 N O3,119.0583,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Threonine,4,9,1,3,0,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,6418755.47953387,8215351.995894477,1.2798979525063752,0.3560287873487411,0.1409627701564795,0.30872903951326996,Upregulated
Feature0045,NA,C11 H25 N O7,283.16316,NA,NA,Feature0045,11,25,1,7,0,0,0,0,2.272727272727273,0.6363636363636364,-0.7272727272727275,81.02727272727273,0,-7,-2.6666666666666665,-0.6923076923076923,-8,Other,109920.5084109314,193565.36511860535,1.7609576949459924,0.816360250438432,0.1314048408685224,0.30419952379023063,Upregulated
Feature0044,NA,C8 H9 N3 O5 P2,289.00169,NA,NA,Feature0044,8,9,3,5,0,2,0,0,1.125,0.625,0,60.3,7,2,1.5,-1,-3,Lignin,161801.68161395134,285027.07671411335,1.7615829073653886,0.8168723756164042,0.11195537098320468,0.2809171845669831,Upregulated
Feature0043,NA,C7 H7 N3 O6 P2,290.98097,NA,NA,Feature0043,7,7,3,6,0,2,0,0,1,0.8571428571428571,0.5714285714285716,44.014285714285705,7,1,1,1,-4,Tannin,149076.2013337701,285775.75021555764,1.9169776775820027,0.9388335375124546,0.08755747310674883,0.28085732573866523,Upregulated
Feature0042,NA,C19 H30 O16,514.15333,NA,NA,Feature0042,19,30,0,16,0,0,0,0,1.5789473684210529,0.8421052631578947,0.10526315789473673,57.3,5,-11,-3.6666666666666665,-0.2727272727272727,-11,Carbohydrate,98150.45178808979,187471.355103616,1.910040674172067,0.9336033606702027,0.09657741241890143,0.28085732573866523,Upregulated
Feature0041,NA,C16 H39 N7 O11 P2,567.2184,NA,NA,Feature0041,16,39,7,11,0,2,0,0,2.4375,0.6875,-0.375,70.9875,2,-9,4.5,-8.333333333333334,-18,Other,165456.35775947903,1271461.7843499607,7.684574963255641,2.9419654661149943,0.3145414790779273,0.46367752519246175,Upregulated
Feature0040,"Î±,Î±-Trehalose",C12 H22 O11,342.11632,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,"Î±,Î±-Trehalose-peak2",12,22,0,11,0,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,443951.517518027,451389.83121503465,1.0167547883124548,0.02397178505464763,0.969782826894427,0.9821555262770645,Upregulated
Feature0039,NA,C13 H16 N7 O5 P S2,445.03926,NA,NA,Feature0039,13,16,7,5,2,1,0,0,1.2307692307692308,0.38461538461538464,1.076923076923077,29.6076923076923,10,5,2.5,-5,-5,Lignin,284008.006229539,603205.8287178813,2.1239043107480655,1.08671876919338,0.23618311111665696,0.38281812323173786,Upregulated
Feature0038,(6-Hydroxy-1-oxo-1H-isochromen-3-yl)methyl hydrogen sulfate,C10 H8 O7 S,271.99907,Other,NA,(6-Hydroxy-1-oxo-1H-isochromen-3-yl)methyl hydrogen sulfate,10,8,0,7,1,0,0,0,0.8,0.7,0.7999999999999998,37.5,7,0,-0.5,0.4545454545454546,-1,Condensed HC,126657.35051066239,224940.615623824,1.7759775861163922,0.8286133741414089,0.045587752260305696,0.24912498754207058,Upregulated
Feature0037,NA,C16 H26 N2 O10,406.15889,NA,NA,Feature0037,16,26,2,10,0,0,0,0,1.625,0.625,0,60.3,5,-5,-1.75,-0.2222222222222222,-7,Amino Sugar,285546.4343814703,580146.7840565534,2.0317073309397986,1.0226925957066553,0.027518123119467348,0.22954141724043495,Upregulated
Feature0036,Linoleic acid,C18 H32 O2,280.24026,Metabolic pathways;Biosynthesis of plant secondary metabolites;Other,Other,Linoleic acid,18,32,0,2,0,0,0,0,1.7777777777777777,0.1111111111111111,-1.5555555555555554,104.63333333333333,3,1,0.0625,0.1176470588235294,1,Lipid,7564156.286506023,6752238.117032543,0.8926624280725279,-0.16381339033517847,0.7612011318027941,0.8418556438101702,Downregulated
Feature0035,trimetaphosphoric acid,H3 O9 P3,239.89901,NA,NA,trimetaphosphoric acid,0,3,0,9,0,3,0,0,Inf,Inf,NA,NA,1,-8,0.9166666666666666,0.8666666666666667,-11,Other,9998375.850568153,19631390.267819833,1.96345792168878,0.9733966803463472,0.08976266963034107,0.28085732573866523,Upregulated
Feature0034,Monomethyl phthalate,C9 H8 O4,180.04223,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of chorismate metabolism;Other,Monomethyl phthalate,9,8,0,4,0,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,2845864.093597943,563102.969402311,0.19786713310346327,-2.3373961027472068,0.2730591672250358,0.42253987173455193,Downregulated
Feature0033,NA,C10 H6 S,158.01901,NA,NA,Feature0033,10,6,0,0,1,0,0,0,0.6,0,-0.4000000000000003,71.7,8,8,0.7777777777777778,0.7777777777777778,7,Condensed HC,354318.06251630734,778746.7763532447,2.1978749003726086,1.136109272661896,0.13577574246939147,0.30872903951326996,Upregulated
Feature0032,3-[(2Z)-1-Oxo-2-buten-2-yl]pentanedioic acid,C9 H12 O5,200.06847,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,3-[(2Z)-1-Oxo-2-buten-2-yl]pentanedioic acid-peak1,9,12,0,5,0,0,0,0,1.3333333333333333,0.5555555555555556,-0.22222222222222232,66.63333333333333,4,-1,-0.25,0.2307692307692308,-1,Lignin,2521839.533152283,3017914.65680889,1.1967116135405,0.2590755300242979,0.23997941633093772,0.3854159587309784,Upregulated
Feature0031,1-(beta-D-ribofuranosyl)thymine,C10 H14 N2 O6,258.08519,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,1-(beta-D-ribofuranosyl)thymine,10,14,2,6,0,0,0,0,1.4,0.6,0.3999999999999999,48.9,5,-1,-1.5,0,-3,Lignin,661973.163559154,1071954.1650232812,1.6193317554745423,0.6953985835073591,0.13853223280137247,0.30872903951326996,Upregulated
Feature0030,Leucylproline,C11 H20 N2 O3,228.14735,NA,NA,Leucylproline,11,20,2,3,0,0,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,4964591.22513158,7970866.26712675,1.6055433178016572,0.6830615897192863,0.11699686524678835,0.28618335204303436,Upregulated
Feature0029,"3,4-Dihydroxyphenylpropionic acid",C9 H10 O4,182.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"3,4-Dihydroxyphenylpropionic acid",9,10,0,4,0,0,0,0,1.1111111111111112,0.4444444444444444,-0.22222222222222232,66.63333333333333,5,1,0.2,0.42857142857142855,1,Lignin,798351.885244283,490115.675538343,0.6139093357165123,-0.7039024858232866,0.2831216757039867,0.4303449470700598,Downregulated
Feature0028,4-Pyridoxic acid,C8 H9 N O4,183.0532,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,4-Pyridoxic acid,8,9,1,4,0,0,0,0,1.125,0.5,0.25,53.175,5,1,0,0.4,0,Lignin,11994144.049450627,14012878.390342934,1.1683099963256462,0.22442312594996197,0.44875710223041587,0.5836426779414513,Upregulated
Feature0027,Succinic anhydride,C4 H4 O3,100.01606,NA,NA,Succinic anhydride,4,4,0,3,0,0,0,0,1,0.75,0.5,46.05,3,0,0,0.6,0,Tannin,452024.685316069,770904.6046604157,1.705448020214596,0.770150784197034,0.22466086444184927,0.3748000762883534,Upregulated
Feature0026,"2-(Hydroxymethyl)-5-methoxy-4-methyl-1,3-benzenediol",C9 H12 O4,184.07352,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"2-(Hydroxymethyl)-5-methoxy-4-methyl-1,3-benzenediol",9,12,0,4,0,0,0,0,1.3333333333333333,0.4444444444444444,-0.44444444444444464,72.96666666666667,4,0,0,0.2857142857142857,0,Lignin,238586.11469536737,84008.0283646084,0.3521077849474682,-1.5059109699841158,0.25616872666430685,0.4037313572313039,Downregulated
Feature0025,100-1,C31 H34 O10,566.21508,Biosynthesis of secondary metabolites;Other,NA,100-1,31,34,0,10,0,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,39947.64661424136,92271.72558119077,2.3098163071337434,1.2077781229293165,0.02535457095371608,0.22954141724043495,Upregulated
Feature0024,2-Oxo-4-pentenoic acid,C5 H6 O3,114.03175,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,2-Oxo-4-pentenoic acid,5,6,0,3,0,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Lignin,165169.16404896133,578698.7067371367,3.5036727955200657,1.808868049390484,0.022297101092497773,0.22428260510688935,Upregulated
Feature0023,2-Hydroxycaproic acid,C6 H12 O3,132.0787,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,2-Hydroxycaproic acid,6,12,0,3,0,0,0,0,2,0.5,-1,88.8,1,-2,-0.6666666666666666,-0.1111111111111111,-2,Protein,1360142.7800437394,207386.121638045,0.15247378781172952,-2.713366848568464,0.16679383910853635,0.32783616652367487,Downregulated
Feature0022,Caffeic acid,C9 H8 O4,180.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of chorismate metabolism;Other,Caffeic acid,9,8,0,4,0,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,6730256.607138936,2152646.1448927065,0.31984607282422867,-1.644550325401586,0.016565635676875353,0.20510808338839256,Downregulated
Feature0021,NA,C6 H15 N O9,245.07472,NA,NA,Feature0021,6,15,1,9,0,0,0,0,2.5,1.5,1,31.799999999999997,0,-9,2.5,-11,-10,Carbohydrate,15278018.5398266,24001151.844397932,1.5709597276526368,0.6516461968889266,0.07563083747115916,0.2798606815761545,Upregulated
Feature0020,NA,C27 H24 N6 O8,560.16569,NA,NA,Feature0020,27,24,6,8,0,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Lignin,74139.37846306646,130941.83191539223,1.7661576699165706,0.8206141422236397,0.07978950534922306,0.2798606815761545,Upregulated
Feature0019,4-Methylphenol,C7 H8 O,108.05753,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,4-Methylphenol,7,8,0,1,0,0,0,0,1.1428571428571428,0.14285714285714285,-0.8571428571428568,84.72857142857141,4,3,0.5,0.5384615384615384,3,Lignin,6513950.796750226,237301.5501033355,0.036429742487727096,-4.778739392689971,0.18671175469691248,0.3462599380783044,Downregulated
Feature0018,NA,C10 H3 N2 O4 P,245.98313,NA,NA,Feature0018,10,3,2,4,0,1,0,0,0.3,0.4,0.6000000000000001,43.2,11,7,1.3333333333333333,1.2,4,Condensed HC,1759432.9054388034,652906.1915116247,0.37108899662689304,-1.4301628713975023,0.018181301531469973,0.20687982476778247,Downregulated
Feature0017,Dimethyl phthalate,C10 H10 O4,194.058,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,Superpathway of scopolin and esculin biosynthesis;Other,Dimethyl phthalate,10,10,0,4,0,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,380273.175443353,236227.367135918,0.6212043930274733,-0.6868600626886446,0.6327472504679807,0.7410943823974295,Downregulated
Feature0016,Polygonolide,C12 H12 O4,220.07345,NA,NA,Polygonolide,12,12,0,4,0,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,7,3,0.375,0.5,3,Lignin,121582.6368292343,134716.443023099,1.1080236992417878,0.14798873916052047,0.751600578884959,0.8345694739566754,Upregulated
Feature0015,Ethylmalonic acid,C5 H8 O4,132.04231,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of L-lysine degradation;Other,Ethylmalonic acid,5,8,0,4,0,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,3706361.7813704167,2956614.1286975527,0.7977133110854475,-0.32605774316250197,0.874478653221342,0.9145923529103943,Downregulated
Feature0014,[3-(4-Methoxyphenyl)-2-oxiranyl]methyl hydrogen sulfate,C10 H12 O6 S,260.03538,NA,NA,[3-(4-Methoxyphenyl)-2-oxiranyl]methyl hydrogen sulfate,10,12,0,6,1,0,0,0,1.2,0.6,0.20000000000000015,54.599999999999994,5,-1,-0.6666666666666666,0.16666666666666666,-2,Lignin,2179723.2852171767,1518673.2701561367,0.6967275527383393,-0.5213334777516885,0.6198466879620106,0.7284796126563836,Downregulated
Feature0013,NA,C10 H16 O8,264.08464,NA,NA,Feature0013,10,16,0,8,0,0,0,0,1.6,0.8,0,60.3,3,-5,-2.5,-0.16666666666666666,-5,Carbohydrate,98950.1727687698,184239.24791431733,1.8619396283910894,0.8968062956503038,0.09656148606828037,0.28085732573866523,Upregulated
Feature0012,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,NA,.alpha.-Glucoheptitol-peak1,7,16,0,7,0,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,14689739.762123499,10260278.071676267,0.6984656119049638,-0.5177390068194611,0.031122798361924886,0.2313912399951807,Downregulated
Feature0011,2-Oxobutyric acid,C4 H6 O3,102.03169,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of L-lysine degradation;Other,2-Oxobutyric acid-peak2,4,6,0,3,0,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,1047539.0882326047,1227445.7307055714,1.1717421760141695,0.22865516165009916,0.7655470913010612,0.8418556438101702,Upregulated
Feature0010,2-Hydroxyvaleric acid,C5 H10 O3,118.06305,Metabolic pathways;Other,NA,2-Hydroxyvaleric acid,5,10,0,3,0,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,2419528.4231378334,703046.5493730623,0.2905717257337678,-1.783033767443854,0.09301851752976283,0.28085732573866523,Downregulated
Feature0009,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09471,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak1",14,16,0,6,0,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,37036.36041932603,58054.40839878383,1.5674976628775412,0.6484632919858502,0.1039707737859206,0.28085732573866523,Upregulated
Feature0008,"Î±,Î±-Trehalose",C12 H22 O11,342.11636,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,"Î±,Î±-Trehalose-peak1",12,22,0,11,0,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,1282176.4167288665,3028714.19332741,2.3621665114184305,1.2401106652983929,0.21071756508457148,0.3633242614204069,Upregulated
Feature0007,Cytidine,C9 H13 N3 O5,243.08554,Metabolic pathways;ABC transporters;Other,Other,Cytidine,9,13,3,5,0,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Lignin,224524.23893976098,418310.4471321933,1.8630970495992838,0.8977028268983765,0.04440606689673733,0.24912498754207058,Upregulated
Feature0006,D-(â)-Erythrose,C4 H8 O4,120.04223,NA,NA,D-(â)-Erythrose-peak1,4,8,0,4,0,0,0,0,2,1,0,60.3,1,-3,-Inf,-0.5,-3,Carbohydrate,30115288.052689433,54966865.02578067,1.825214652757468,0.8680661408464997,0.16408577968907942,0.32437766851829575,Upregulated
Feature0005,Thymidine,C10 H14 N2 O5,242.09031,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Thymidine,10,14,2,5,0,0,0,0,1.4,0.5,0.20000000000000015,54.599999999999994,5,0,-0.6666666666666666,0.09090909090909093,-2,Lignin,47493178.23266433,59986895.9024198,1.2630634153088258,0.33692707511501657,0.24790848162868187,0.39252176257874627,Upregulated
Feature0004,2-Oxobutyric acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of L-lysine degradation;Other,2-Oxobutyric acid-peak1,4,6,0,3,0,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,1019149.900093099,1728585.2381410967,1.6961049969029982,0.7622254822964837,0.02852989236956729,0.2313912399951807,Upregulated
Feature0003,NA,C9 H16 O7,236.0896,NA,NA,Feature0003,9,16,0,7,0,0,0,0,1.7777777777777777,0.7777777777777778,-0.22222222222222232,66.63333333333333,2,-5,-2.5,-0.2727272727272727,-5,Carbohydrate,47819548.280713744,1970488.752205317,0.041206762151704414,-4.600975082409571,0.19433433942947018,0.3516526142057079,Downregulated
Feature0002,L-Iditol,C6 H14 O6,182.079,Metabolic pathways;ABC transporters;Galactose metabolism;Fructose and mannose metabolism;Phosphotransferase system (PTS);Other,Other,L-Iditol-peak1,6,14,0,6,0,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,2219348.940644418,479801.53271822835,0.21619021864083776,-2.209626843959036,0.22214741310264077,0.3724236043191331,Downregulated
Feature0001,"L-Fucono-1,5-lactone",C6 H10 O5,162.05279,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Fructose and mannose metabolism;Other,Superpathway of butirocin biosynthesis;Other,"L-Fucono-1,5-lactone",6,10,0,5,0,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,11276697.812804254,6276690.1035212,0.5566071032243376,-0.8452687749330117,0.10925444771365435,0.2809171845669831,Downregulated
